case_id,mode,case_type,iteration,Q0_answer,Q0_reasoning,Q1_answer,Q1_reasoning,Q2_answer,Q2_reasoning,Q3_answer,Q3_reasoning,Q4_answer,Q4_reasoning,Q5_answer,Q5_reasoning,Q6_answer,Q6_reasoning,Q7_answer,Q7_reasoning,Q8_answer,Q8_reasoning,input_tokens,output_tokens,total_tokens
Case3223,rag,all_correct,iter1,BRCA1/2,Patient was referred specifically for BRCA1 and BRCA2 testing per the clinical information.,Not Specified,"The BCBS_FEP policy does not impose an upper age limit for BRCA1/2 testing in adults (only states testing in minors is investigational), so no age-based eligibility restriction is specified that would apply to this 75‑year‑old.",No,The policy requires testing be performed in a setting with suitably trained providers able to give pre‑ and post‑test genetic counseling. The ordering provider is a general practitioner and there is no documentation that pre‑test counseling or that the required setting/provider expertise is in place.,Yes,"Policy allows BRCA1/2 testing for an unaffected individual who has a 1st‑ or 2nd‑degree relative meeting any 'Patients With Cancer' criterion. The patient's sister had epithelial ovarian carcinoma, which meets the policy's cancer criterion for relatives.",Not Specified,"The policy strongly recommends testing an affected family member first when possible, but it does not state this is an absolute required prior test for coverage of an unaffected individual.",Yes,"Family history is relevant per policy. The patient has a first‑degree relative (sister) with epithelial ovarian cancer, a family history explicitly cited in the policy as indication for testing.",No,"The policy requires appropriate pre‑ and post‑test genetic counseling by experienced providers. The clinical information states there is no documentation of pre‑test genetic counseling, so counseling requirements are not met.",Not Specified,The provided BCBS_FEP policy document does not specify CPT/billing codes for BRCA1/2 testing; no CPT mapping is given in the policy text.,No,"Although the patient meets medical‑necessity criteria based on family history (sister with epithelial ovarian cancer), the policy requires testing be performed in a setting with suitably trained providers and appropriate pre‑test genetic counseling. There is no documentation that counseling/setting requirements are met, so coverage cannot be approved per the policy requirements.",18927,2187,21114
Case14226,rag,all_correct,iter1,BRCA1/2,Patient info explicitly states oncology is evaluating the patient for germline BRCA1 and BRCA2 (BRCA1/2) testing.,Yes,"Policy requires age 18 years or older for BRCA testing (Known familial, AJ founder, full sequence). Patient is 55, which meets the >=18 requirement (BRCA Analysis criteria).",Not Specified,"The policy specifies genetic counseling and that the rendering laboratory be qualified, but does not impose a specific ordering-provider specialty requirement for BRCA testing; therefore ordering-provider requirements are not specified in the policy.",Not Answerable,"Policy medical-necessity criteria specify particular cancers (e.g., breast, ovarian, pancreatic, prostate) and detailed family-history combos. The patient has a 'primary solid tumor' unspecified in type, so available clinical information is insufficient to determine whether the patient's diagnosis meets the policy's specific diagnostic criteria.",No,"The policy requires pre-test genetic counseling for BRCA testing. Patient information states no pre-test genetic counseling was completed, so required prior testing/processes were not completed (patient has had no prior genetic testing, which would satisfy other prior-test requirements).",No,"The policy defines family-history criteria for eligibility (specific cancer types in 1st–3rd degree relatives). The patient’s family history notes a mother with a hematologic/immunologic disorder, which is not one of the BRCA-relevant cancers; thus the patient does not have the family history specified by the policy.",No,"BRCA criteria in the policy require pre- and post-test genetic counseling. Patient data explicitly states no pre-test genetic counseling was completed, so counseling requirements are not met.",81162,"Policy lists CPT 81162 as appropriate for BRCA1/2 full sequencing when deletion/duplication analysis is performed concurrently (BRCA1/2 full sequencing and duplication/deletion analysis combined), which corresponds to typical comprehensive germline BRCA1/2 testing requested.",No,"Per the policy the member must meet defined clinical criteria and pre-test genetic counseling is required. The clinical indication is indeterminate from the record (tumor type unspecified vs. policy-specified cancer types) and required pre-test genetic counseling was not completed, so coverage criteria are not met.",10313,2426,12739
Case10451,rag,all_correct,iter1,WES,Patient was referred by neurology for whole exome sequencing (WES) to evaluate an unexplained neurodevelopmental disorder (patient info).,Yes,"Policy lists 'moderate, severe, or profound Intellectual Disability diagnosed by 18 years of age' as a qualifying feature for WES; patient is 10 with moderate–severe ID diagnosed in childhood, meeting the age-based criterion (policy Coverage Rationale).",Yes,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the ordering provider is a neurologist (patient info + policy Coverage Rationale).",Yes,"Policy requires nonspecific presentation, an appropriate ordering provider, and at least one qualifying feature (e.g., moderate/severe ID diagnosed <18). Patient has nonspecific unexplained NDD, prior nondiagnostic CMA, neurologist ordered WES, and moderate–severe ID — meeting the medical indication elements of the policy (policy Coverage Rationale).",Not Specified,"Policy does not mandate specific prior diagnostic tests before WES for postnatal NDD (except when a specific syndrome is suspected); patient did have prior CMA nondiagnostic, but no required prior-test sequence is specified for WES in this indication (policy Coverage Rationale).",No,"Policy includes family history of other first- or second-degree members with similar features or consanguinity as possible qualifiers. Patient has a sibling with a brief resolved unexplained event (not described as similar ID/NDD) and no consanguinity, so relevant family-history criteria are not met (patient info + policy Coverage Rationale/Definitions).",Not Specified,"Policy 'strongly recommends' genetic counseling prior to WES/WGS but does not state counseling as a coverage requirement; patient has no documentation of prior genetic counseling, and the policy does not make counseling a mandatory eligibility criterion (policy Description of Services).",81415,Applicable CPT code list in the policy indicates 81415 is the code for exome sequence analysis (WES) for unexplained constitutional/heritable disorder (policy Applicable Codes).,Yes,"Under the UnitedHealthcare policy WES is proven/medically necessary when presentation is nonspecific, ordered by an allowed specialty, and the patient has qualifying features such as moderate/severe ID diagnosed <18. The patient is a 10-year-old with moderate–severe ID, nonspecific unexplained NDD, prior nondiagnostic CMA, and WES ordered by a neurologist — meeting policy coverage criteria for WES (policy Coverage Rationale + patient info).",36961,2559,39520
Case4196,rag,all_correct,iter1,WES,Patient information explicitly states whole exome sequencing (WES) is being requested as the next diagnostic step.,Yes,Policy states WES may be medically necessary for evaluation of unexplained congenital or neurodevelopmental disorders in children; the patient is a 10-year-old child and therefore meets the age-based (child) criterion.,Not Answerable,"Policy requires documentation that the individual has been evaluated by a clinician with expertise in clinical genetics. Patient data notes referral by a cardiologist and that pre-test genetic counseling was completed, but does not explicitly document evaluation by a clinician with expertise in clinical genetics, so this cannot be confirmed from the provided information.",Yes,"Policy indication: WES is appropriate for children with unexplained neurodevelopmental disorders. The patient has nonsyndromic developmental delay and intellectual disability and prior genetic testing (FISH) was nondiagnostic, meeting the policy's clinical indication criteria.",Not Specified,"Policy gives examples of prior testing (eg, chromosomal microarray and/or targeted single-gene testing) or prior genetic testing that failed to yield a diagnosis, but does not mandate a single specific prior test. The patient had prior FISH testing that was nondiagnostic; the policy does not explicitly require CMA first, so specific prior test requirements are not strictly specified.",Yes,"Policy guidance lists family history of developmental delay as a relevant criterion. The patient has a brother diagnosed with moderate to severe intellectual disability, which is relevant per policy.",Yes,"Policy requires counseling and evaluation including family history and phenotype. Patient information states pre-test genetic counseling was completed with plans for post-test follow-up, satisfying the counseling requirement.",81415,The requested test is whole exome sequencing; CPT code 81415 corresponds to clinical whole exome sequencing (interpretation and report).,Yes,"Based on the FEP policy, WES may be considered medically necessary for children with unexplained neurodevelopmental disorders when criteria are met. The patient is a child with unexplained developmental delay/ID, prior genetic testing was nondiagnostic, pre-test genetic counseling was completed, and there is relevant family history—together these facts meet the policy's medical-necessity criteria for standard WES.",14850,3629,18479
Case18281,rag,all_correct,iter1,WGS,Patient clinical info states the cardiologist ordered whole genome sequencing (WGS).,Not Specified,"The UnitedHealthcare WGS policy does not impose an explicit age cutoff for WGS eligibility; age-specific items exist for some features (e.g., ID diagnosed by 18 years) but no absolute age restriction preventing a 6-year-old from WGS is specified.",No,"Policy requires WGS to be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the ordering provider here is a cardiologist, which does not meet the listed ordering-provider requirement.",Yes,"Policy lists 'multiple congenital anomalies (must affect different organ systems)' as an indication for WGS. The patient is a 6-year-old with multiple congenital anomalies that do not fit a well-delineated syndrome, which matches the clinical criterion.",Yes,"Policy states WGS is appropriate when 'Neither CMA nor WES have been performed.' Patient history documents only Fragile X testing (nondiagnostic) and no prior CMA or WES, satisfying this prior-test requirement.",No,"The policy specifies family-history criteria such as 'other first- or second-degree family member(s) with similar clinical features' or consanguinity. The patient has a sibling with an inborn error of metabolism, which is not documented as 'similar clinical features' for the proband and consanguinity is not present; thus the policy-specified family/consanguinity criteria are not met.",Not Specified,"The policy states genetic counseling is 'strongly recommended' prior to WGS but does not make pretest genetic counseling a listed mandatory coverage requirement; the patient had no prior counseling, but the policy does not explicitly require it for coverage.",81425,"Policy's Applicable Codes list CPT 81425 for 'Genome (e.g., unexplained constitutional or heritable disorder or syndrome); sequence analysis,' which corresponds to WGS as requested.",No,"Although the patient meets medical-indication criteria (multiple congenital anomalies) and has not had CMA/WES, the policy additionally requires WGS be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The ordering provider is a cardiologist, so the ordering-provider requirement is unmet and coverage under this policy would be denied.",36944,2115,39059
Case17196,rag,all_correct,iter1,CMA,"Patient was referred for chromosomal microarray testing (CMA) per the clinical information; the policy provided is the BCBS FEP CMA policy (FEP 2.04.59), confirming CMA is the requested test.",Not Specified,"The policy describes CMA as first‑line for individuals with developmental delay/ID, ASD, or multiple congenital anomalies but does not impose an explicit age cutoff for eligibility; the patient is 63 but no age-based exclusion is specified in the policy.",Not Specified,The policy discusses the role of genetic counseling and clinical geneticists but does not define specific ordering‑provider specialty/type requirements for CMA; the ordering provider (oncologist) is noted in the patient info but the policy has no explicit ordering‑provider requirement.,No,"Policy medical‑necessity criteria are explicit: CMA is medically necessary for apparent nonsyndromic developmental delay/intellectual disability, autism spectrum disorder, or multiple congenital anomalies. The patient has adult neuropsychiatric diagnoses (bipolar/schizophrenia/OCD features) and does not meet any of the policy‑listed indications.",Not Specified,"The policy does not require completion of specific prior tests before CMA (CMA is described as a first‑line test for the listed indications). Although the patient had a nondiagnostic karyotype, the policy does not mandate prior testing as a coverage prerequisite.",Not Specified,"The policy does not define family history or consanguinity as an independent eligibility criterion for CMA (it notes parental evaluation/follow‑up if a CNV is found), and the patient’s sibling history is not addressed as a coverage criterion in the policy.",Not Specified,"The policy states experts recommend formal genetic counseling and that it should be performed by experienced individuals, but it does not state genetic counseling is a mandatory coverage requirement prior to CMA; the patient had no pre‑test counseling, and the policy does not make lack of counseling an explicit denial criterion.",Not Specified,The policy document does not list or map CPT/billing codes to CMA; no CPT code guidance for CMA is provided in the supplied policy text.,No,"Under the policy CMA is covered only for evaluation of developmental delay/intellectual disability, autism spectrum disorder, or multiple congenital anomalies. The patient's indication is adult neuropsychiatric disease (bipolar/schizophrenia/OCD features), which is not among the policy‑listed medically necessary indications; therefore CMA is not covered for this presentation per the policy.",15705,1963,17668
Case8288,rag,all_correct,iter1,WES,Patient information states whole exome sequencing (WES) is being pursued to evaluate the fetal cardiac anomaly.,Not Specified,The policy does not impose an age limit for prenatal WES; prenatal criteria are phenotype- and testing-based rather than age-based.,No,Policy requires prenatal WES to be ordered by or in consultation with a medical geneticist or maternal-fetal medicine specialist; the record only documents referral by a developmental pediatrician and does not document ordering by/consultation with the required specialists.,Yes,"Per policy prenatal WES is indicated when CMA/karyotype is uninformative and the fetus has a congenital anomaly affecting a single organ system plus family history suggesting a genetic etiology — the patient has a nondiagnostic CMA, a major fetal cardiac anomaly (single organ system), and a sibling with an inborn error of metabolism.",Yes,Policy requires CMA and/or karyotyping to have been performed and uninformative prior to prenatal WES; the patient had a CMA previously that was nondiagnostic.,Yes,Policy lists family history as a relevant criterion for prenatal WES; the patient has a family history of an inborn error of metabolism in an older sibling.,Yes,"The policy strongly recommends genetic counseling prior to WES/WGS and the parents have had multiple sessions with a genetic counselor, meeting the counseling recommendation.",81415,Policy applicable CPT codes list 81415 for exome (sequence analysis) which corresponds to WES.,No,"Although clinical criteria are met (nondiagnostic CMA, fetal congenital anomaly, supportive family history, and genetic counseling), prenatal WES coverage requires the test be ordered by or in consultation with a medical geneticist or maternal-fetal medicine specialist and an appropriate fetal sample be obtained; the provided record does not document that ordering/consultation or sample type, so not all policy-required conditions for coverage are satisfied.",36980,1965,38945
Case3422,rag,all_correct,iter1,WES,Patient info explicitly states consideration of whole-exome sequencing (WES) after nondiagnostic CMA.,No,"Policy Exome Sequencing criteria require the member be <21 years of age. The patient is 34, so does not meet the age-based requirement.",Not Specified,The policy does not mandate a specific ordering provider specialty; it requires appropriate genetic/family history evaluation and counseling documentation but does not explicitly restrict who may order ES.,No,"Policy defines specific clinical indications (e.g., multiple congenital anomalies, developmental delay, epilepsy, etc.). The patient has a single congenital anomaly (choanal atresia) with no listed neurodevelopmental criteria, so does not meet the specified medical indications.",Yes,"Policy expects prior standard testing (e.g., CMA) and no prior ES/WGS. Patient had a nondiagnostic CMA and no prior ES/WGS, satisfying prior-test requirements.",Not Specified,The guideline requires an appropriate genetic/family history evaluation but does not specify family history/consanguinity criteria that would make this adult proband eligible for ES; the provided maternal breast cancer history is not a policy-specified criterion for ES in this context.,Yes,"Policy and ACMG recommend pretest counseling by a medical geneticist or affiliated genetic counselor. Patient has seen a genetic counselor multiple times, meeting the counseling requirement.",81415,Policy billing section states CPT 81415 should be billed for proband whole-exome sequencing (analyzing the entire exome).,No,"Although prior CMA and genetic counseling are documented, the policy requires the member to be <21 years old for ES to be medically necessary; the patient is 34, therefore ES is not covered per the policy criteria.",10464,1870,12334
Case5885,rag,all_correct,iter1,WGS,Patient information explicitly states whole genome sequencing (WGS) is requested.,Not Specified,"The policy does not impose an absolute age limit for WGS; it references age-related diagnostic criteria (e.g., ID diagnosed by 18) but no explicit age-based eligibility cutoff. The patient is 11 and no age exclusion applies per policy.",Yes,"Policy requires WGS be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The test was requested by/through neurology, meeting the ordering-provider requirement (policy: Coverage Rationale for WGS).",No,"Policy coverage for WGS requires clinical presentation that suggests a genetic cause plus specified features (e.g., multiple congenital anomalies, global developmental delay, moderate–severe ID, or two or more listed features). The patient has a 'major abnormality affecting at least one organ system' but no documentation of the required listed features (multiple congenital anomalies, ID/GDD, epilepsy, two or more of the enumerated features, consanguinity, or another family member with similar features). Thus the defined medical indications are not met.",Yes,"Policy states WGS is proven/medically necessary when 'neither CMA nor WES have been performed.' Patient has only prior Fragile X testing (nondiagnostic) and no record of prior CMA or WES, satisfying the policy prerequisite for WGS.",No,"Policy lists family history (other first/second-degree with similar clinical features) and consanguinity as relevant features. The patient has a maternal history of long QT syndrome, which is not documented as 'similar clinical features' to the proband, and no consanguinity—so relevant family/consanguinity criteria are not met per policy.",Yes,"Policy 'strongly recommends' genetic counseling prior to WGS. Patient information documents pre-test counseling was discussed with a genetic specialist and post-test follow-up plans are in place, meeting the counseling expectation in the policy.",81425,"Policy's applicable CPT codes list 81425 for 'Genome (e.g., unexplained constitutional or heritable disorder or syndrome); sequence analysis,' which corresponds to WGS.",No,"Although ordering provider and prior-test and counseling conditions are met, the policy requires specific clinical indications (e.g., multiple congenital anomalies, GDD/ID, epilepsy onset <3y, or two or more listed features) to support WGS. The patient's record documents a major single-organ abnormality without the required listed features or family history of similar phenotype; therefore WGS does not meet the policy's medical necessity criteria and is not covered.",36937,3012,39949
Case14195,rag,all_correct,iter1,BRCA1/2,Patient was referred for BRCA1/2 testing per the clinical information; policy FEP 2.04.02 specifically addresses BRCA1 and BRCA2 testing and is the applicable document.,Yes,"Policy explicitly states testing of minors for BRCA1/2/PALB2 is considered investigational. The patient is 18 years old (an adult), so age does not preclude testing under the policy.",Not Specified,Policy requires testing be performed in a setting with 'suitably trained health care providers' able to give pre- and post-test counseling but does not specify exact ordering-provider specialties or credentials; the ordering provider (oncologist) is noted in the patient info but the policy does not explicitly list allowed ordering provider types.,No,"Policy medical necessity criteria require a personal history of qualifying cancers or a family history of cancers meeting specific criteria. The patient has no personal cancer history and a family history limited to a maternal uncle with dystonia/ataxia (non-cancer), which does not meet the policy's family/cancer criteria.",Not Specified,"Policy recommends testing an affected family member first when possible and describes testing strategies, but it does not state a specific required prior diagnostic test that must be completed before testing an unaffected individual in all situations; the patient had prior nondiagnostic karyotype (not referenced as a required prior test in this policy).",No,"Policy specifies family-history criteria (breast, ovarian, pancreatic, prostate, etc.) for eligibility. The provided family history (maternal uncle with dystonia and ataxia) is not a qualifying cancer family history per the policy.",No,"Policy states testing should be performed in a setting with appropriate pre- and post-test genetic counseling and that genetic counseling is recommended; the patient information states no pretest genetic counseling has been conducted, so counseling requirements are not met.",Not Specified,The policy document (FEP 2.04.02) does not provide or map specific CPT codes for BRCA1/2 testing; therefore an appropriate CPT code cannot be determined from the provided policy text.,No,"Adjudication based on the policy: patient does not meet medical necessity criteria (no personal qualifying cancer history and no family cancer history meeting policy criteria), and required pre-test genetic counseling has not been completed; therefore BRCA1/2 testing is not covered under the policy for this patient.",18924,2139,21063
Case2847,rag,all_correct,iter1,WES,The patient information explicitly states 'whole exome sequencing (WES) is being pursued.',Yes,"Policy criteria apply to children/infants; the patient is a 5-week-old infant (a child), which meets the policy's age scope for pediatric WES.",Not Answerable,"The policy requires documentation that the individual has been evaluated by a clinician with expertise in clinical genetics. The patient record documents pre-test counseling by a genetic counselor but does not explicitly state evaluation by a clinician with expertise in clinical genetics, so available information is insufficient to determine if ordering/provider requirements are met.",Yes,"Policy lists an infant with a high-risk BRUE requiring CPR as a clinical feature suggesting a genetic disease. The patient had a high-risk BRUE requiring CPR, so a defined medical indication in the policy is met.",Yes,"Policy criteria allow WES when previous genetic testing has failed to yield a diagnosis. The patient had prior CMA testing that was nondiagnostic, satisfying the prior-testing pathway in the policy.",No,"The policy specifies relevant family history examples (arrhythmia, BRUE in sibling, developmental delay, inborn errors, LQTS, sudden unexplained death). The patient's reported family history (mother with immunologic/hematologic disorder) is not among the policy's specified relevant family-history criteria.",Yes,"The policy requires counseling and states genetic counseling should be performed by someone with expertise. The patient had pre-test counseling completed with a genetic counselor and plans for post-test follow-up, which satisfies the policy's counseling requirement as documented.",Not Specified,"The policy document does not list or map specific CPT codes to WES, so a CPT code is not specified in the provided policy text.",Yes,"Based on the policy: the patient is a pediatric infant, has a high-risk BRUE requiring CPR (an example clinical feature supporting WES), and prior CMA was nondiagnostic (policy pathway allows WES when prior testing failed). Pre-test genetic counseling was completed. Although evaluation by a clinician with expertise in clinical genetics is required by the policy, the record documents genetic counseling (but does not explicitly document a genetics clinician evaluation). Given the documented high-risk BRUE with CPR, nondiagnostic CMA, infant age, and completed genetic counseling, the test meets the policy's medical-necessity criteria for WES.",14852,3143,17995
Case11855,rag,all_correct,iter1,CMA,Patient information explicitly states chromosomal microarray (CMA) is being ordered to assess for copy number variants.,Not Specified,"The UnitedHealthcare CMA policy does not impose an age cutoff for testing; it describes indications across prenatal, pediatric and adult settings but does not specify age-based eligibility criteria that would exclude a 14-year-old.",Not Specified,The policy strongly recommends pre/post-test genetic counseling by qualified genetics personnel but does not mandate a specific provider specialty to place the CMA order; no explicit ordering-provider restriction is stated.,No,"Policy coverage rationale lists specific covered indications (ASD, isolated severe congenital heart disease, multiple anomalies not specific to a well-delineated syndrome, developmental delay/intellectual disability). The patient has a congenital anomaly affecting a single organ system without documentation of DD/ID, ASD, multiple anomalies, or isolated severe CHD, so the defined medical indications are not met.",Yes,"The AAN/other guidance in the policy states targeted testing (e.g., Fragile X/FMR1) when indicated should be negative prior to CMA; the patient had prior Fragile X testing that was nondiagnostic, satisfying this prior-test expectation.",No,The policy only specifies family-related indications such as testing a parent/sibling of a child with an abnormal/equivocal CMA; the patient's family history (maternal aunt with breast cancer) does not match the family-history criteria for CMA eligibility.,Yes,"Policy strongly recommends pre-test genetic counseling and AAN guidance requires face-to-face counseling/consent; the patient received pre-test counseling with a genetic specialist and plans for post-test follow-up were made, meeting counseling expectations.",81228,"The policy lists CPT 81228 for genome-wide cytogenomic analysis (CGH microarray) for constitutional copy number variant detection, which corresponds to the requested CMA.",No,"Based on the UnitedHealthcare CMA coverage rationale the test is medically necessary only for the listed indications (ASD, isolated severe CHD, multiple anomalies not specific to a well-delineated syndrome, developmental delay/ID, etc.). The patient has a single-organ congenital anomaly without documented DD/ID, ASD, multiple anomalies, or isolated severe CHD, so the coverage criteria are not met and the test is not covered per policy.",30417,2494,32911
Case3465,rag,all_correct,iter1,WGS,Patient record states whole genome sequencing (WGS) has been ordered.,Yes,"Policy age-related criteria for WGS include Global Developmental Delay (onset <5 years) or intellectual disability diagnosed by age 18; the patient is a 2-year-old with developmental delay/intellectual disability, meeting these age-relevant criteria.",Yes,"Policy requires WGS be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the patient is being evaluated by a medical geneticist who ordered WGS.",Yes,Policy medical necessity for WGS includes nonspecific presentation without a well-defined syndrome plus presence of Global Developmental Delay or intellectual disability; the patient has developmental delay/intellectual disability without a specific syndrome.,Not Answerable,"Policy states WGS is indicated when 'Neither CMA nor WES have been performed.' Patient history documents prior Fragile X testing (nondiagnostic) but does not state whether chromosome microarray (CMA) or WES were performed, so required prior-test status is unknown.",No,"Policy lists family history of similar clinical features or consanguinity as relevant criteria; the patient has a paternal history of Long QT syndrome, which is not a similar neurodevelopmental phenotype or consanguinity, so relevant family-history criteria are not met.",Not Specified,"Policy 'strongly recommends' genetic counseling prior to WES/WGS but does not state counseling as a formal coverage requirement; patient received pre-test counseling and plans post-test counseling, which meets the recommendation but the policy does not make it a coverage criterion.",81425,"Policy's applicable CPT codes list 81425 as 'Genome (e.g., unexplained constitutional or heritable disorder or syndrome); sequence analysis' corresponding to WGS.",No,"Although the patient meets clinical indications (nonspecific DD/ID) and the ordering provider requirement, the policy requires that 'Neither CMA nor WES have been performed' before WGS; the record does not indicate whether CMA was performed. Because a required prior-test criterion cannot be confirmed from the documentation, coverage cannot be established per the policy.",36943,2461,39404
Case15557,rag,all_correct,iter1,WGS,Patient clinical information states whole genome sequencing (WGS) is being pursued.,Yes,"Policy age-related criteria are specified for some features (e.g., intellectual disability diagnosed by 18); patient is 15 years old, which meets the policy's age-related thresholds applicable to pediatric indications.",Yes,"Policy requires WGS be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the patient was referred by/being evaluated by neurology (neurologist).",Yes,"Policy requires clinical history suggesting a genetic cause plus either one major feature or two+ listed features. The patient has a congenital anomaly and another first-degree family member (sibling) with similar features (two listed features), satisfying medical indication for WGS.",Yes,"Policy states WGS is appropriate when neither CMA nor WES have been performed. Patient had prior FISH (nondiagnostic) but no CMA or WES, so prior-test requirement is satisfied.",Yes,Policy lists 'other first- or second-degree family member(s) with similar clinical features' as an eligibility feature; patient has a sibling with a similar congenital anomaly.,Yes,"Policy 'strongly recommends' genetic counseling prior to WES/WGS; patient has been seen by a genetic counselor multiple times with plans for post-test counseling, meeting the counseling expectation.",81425,Policy applicable CPT codes list 81425 for genome (sequence analysis) which corresponds to clinical WGS.,Yes,"Per the UnitedHealthcare WES/WGS policy, the patient meets required clinical indications (congenital anomaly + affected sibling), age context, ordering provider specialty (neurologist), and prior-test conditions (no CMA/WES), and counseling expectations—therefore WGS is covered.",36940,1877,38817
Case4982,rag,all_correct,iter1,WES,Patient is being considered for whole exome sequencing (WES) per the clinical information. Basis: patient note explicitly: 'being considered for whole exome sequencing (WES)'.,Not Specified,"The UnitedHealthcare WES policy does not impose a general age cutoff for WES; it references age for specific features (e.g., ID or sensory impairment diagnosed by age 18, epileptic encephalopathy onset <3 years). The policy therefore does not specify a single age-based eligibility requirement that would exclude or require this 11-year-old.",Yes,"Policy requirement: WES must be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. Basis: patient was referred by a developmental pediatrician for genetic evaluation, satisfying the ordering-provider requirement in the policy.",Yes,"Policy requires clinical presentation nonspecific and ordering by an approved specialist plus presence of listed features. Basis: patient has a nonspecific concern for an underlying genetic etiology, prior targeted test (FISH) nondiagnostic, and features meeting policy: a congenital anomaly (Hirschsprung disease) and a first-degree family history of early-onset epileptic encephalopathy (sibling), consistent with 'clinical history strongly suggests a genetic cause' and two or more listed features, supporting medical indication for WES per policy.",Not Specified,Policy does not mandate specific prior testing for outpatient WES except that if a specific syndrome is suspected targeted testing should be done first. Patient had prior FISH testing nondiagnostic; however the policy does not require additional specific prior tests in this scenario.,Yes,"Policy lists 'other first- or second-degree family member(s) with similar clinical features' and consanguinity as relevant features. Basis: patient has a sibling with epileptic encephalopathy before age three, which is relevant family history per the policy.",Yes,"Policy: 'Genetic counseling is strongly recommended prior to WES or WGS' and recommends pre-/post-test counseling. Basis: family has met with a genetic counselor multiple times for pre-test counseling and plans post-test disclosure, meeting the counseling expectations in the policy.",81415,Policy applicable CPT codes list 81415 for exome (sequence analysis) for unexplained constitutional/heritable disorder — code corresponds to WES requested for this patient.,Yes,"Based on UnitedHealthcare WES coverage rationale: WES is medically necessary when presentation is nonspecific, ordered by an approved specialist, and clinical history strongly suggests a genetic cause with supporting features. Basis: patient is 11, referred/managed by a developmental pediatrician (approved ordering provider), has nonspecific presentation with prior nondiagnostic FISH, a congenital anomaly (Hirschsprung disease) and strong family history (sibling with early epileptic encephalopathy). These facts meet the policy's medical necessity criteria for WES.",36969,3192,40161
Case14371,rag,all_correct,iter1,WES,Patient clinical information states the general pediatrician ordered whole exome sequencing (WES).,Yes,"Policy includes age-referenced criteria (e.g., features diagnosed by 18 years, GDD defined by onset <5 yrs) but has no upper age exclusion; the patient is 11 years old and therefore meets the age-related thresholds referenced in the policy (e.g., diagnosis by 18 years).",No,"Policy Coverage Rationale explicitly requires WES to be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The ordering provider is a general pediatrician, which is not listed as an authorized ordering specialty.",Yes,"Policy allows WES when clinical history strongly suggests a genetic cause and relevant features are present. The patient has a complex neurodevelopmental disorder and autism spectrum disorder (both listed as qualifying neurodevelopmental features in the policy), satisfying medical indication criteria.",Not Specified,"The policy does not mandate specific prior testing universally before WES (it only advises targeted single-gene/panel testing when a specific syndrome is suspected). The patient did have prior Fragile X testing (nondiagnostic), but the policy does not require Fragile X specifically as a prerequisite for WES.",No,"The policy lists family history of other first- or second-degree family members with similar clinical features as a supporting feature. The patient has a maternal aunt with a severe immunologic disorder, but that is not described as a family member with similar neurodevelopmental features, so it does not meet the policy's family-history criterion.",Not Specified,"The policy 'strongly recommends' genetic counseling prior to WES/WGS but does not state it as an absolute coverage requirement. The patient did meet the recommendation (pre-test genetic counseling performed), but counseling is not specified as a strict coverage criterion in the policy.",81415,"Applicable CPT codes in the policy list 81415 for exome sequence analysis (proband), which corresponds to WES ordered for this patient.",No,"Although the patient’s clinical presentation (neurodevelopmental disorder/ASD) meets medical indication criteria and pre-test genetic counseling occurred, the policy requires WES to be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The ordering provider is a general pediatrician, so the policy’s provider-ordering requirement is not met and coverage is not supported.",36945,4314,41259
Case15202,rag,all_correct,iter1,BRCA1/2,Patient was referred for BRCA1 and BRCA2 testing to evaluate hereditary breast/ovarian cancer risk; the request is explicitly BRCA1/BRCA2.,No,"Policy specifies age-based criteria for BRCA testing (eg, breast cancer diagnosed ≤45 years, 46–50 with additional features, ≤60 if triple-negative, etc.). The patient is 65 and does not meet the policy's age-based eligibility thresholds.",Yes,"Policy requires testing be performed in a setting with suitably trained providers who can give pre- and post-test counseling. The patient completed pre-test counseling with a genetic specialist and has plans for post-test follow-up, satisfying the provider/counseling setting requirement.",No,"Policy defines specific clinical indications for BRCA1/2 testing (personal history of breast cancer meeting listed age/family criteria, ovarian, pancreatic, certain prostate cancers, or relevant family history). The patient has malignant phyllodes tumor (not listed as an indication) and does not meet the policy's specified personal- or family-history criteria.",Not Specified,The policy does not specify required prior tests for BRCA1/2 testing in this clinical scenario; no mandatory prior diagnostic test completion requirement is defined in the provided policy text.,No,Policy specifies family-history criteria (close relatives with breast/ovarian/pancreatic/prostate cancer). The patient reports a sister with an immunologic/hematologic disorder (not cancer); thus she does not have the relevant family history per policy.,Yes,"Policy states genetic counseling by experienced providers is required/strongly recommended. The patient completed pre-test counseling with a genetic specialist and has plans for post-test follow-up, meeting counseling requirements.",Not Specified,"The provided policy document does not list or map specific CPT codes for BRCA1/2 testing, so the appropriate CPT code is not specified in the policy text.",No,"Per the policy, BRCA1/2 testing is medically necessary only for individuals meeting the enumerated clinical criteria. The patient (age 65, malignant phyllodes tumor, no relevant cancer family history) does not meet those policy criteria, so testing is not covered under this policy.",18954,1903,20857
Case8621,rag,all_correct,iter1,WES,Patient information states the child is undergoing whole exome sequencing (WES).,Not Specified,"The policy does not impose a strict age limit for WES; it lists age-dependent diagnostic features (e.g., ID diagnosed by 18, GDD onset <5, seizures onset <3) but no absolute age exclusion — the 2-year age is not directly constrained by the policy.",No,"UnitedHealthcare policy requires WES to be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The test was ordered by the child’s oncologist, which does not meet the specified ordering-provider requirement.",No,"Policy requires either (A) one major feature (e.g., global developmental delay, multiple congenital anomalies, moderate–severe ID, or early epileptic encephalopathy) or (B) two or more listed features (e.g., autism plus another feature). The record documents autism only (and an uncle with a congenital anomaly), so the explicit medical-necessity criteria in the policy are not met.",Not Specified,"The WES coverage criteria do not mandate prior testing (CMA is not required before WES); although CMA was performed and nondiagnostic in this case, the policy does not define a required prior-test sequence for WES.",Yes,"The policy lists family history (other first- or second-degree relatives with similar features) and consanguinity as relevant criteria. The family reports an uncle with a congenital anomaly (a second-degree relative), which is a documented relevant family history per the policy.",Yes,"The policy states genetic counseling is strongly recommended prior to WES; the family has met with a genetic counselor multiple times with pre-test counseling completed and plans for post-test follow-up, satisfying the counseling recommendation.",81415,Policy applicable CPT codes list 81415 for exome (sequence analysis); WES corresponds to CPT 81415.,No,"Although the patient’s phenotype (neurodevelopmental disorder with autism) and completed genetic counseling are relevant, the policy explicitly requires WES to be ordered by specified specialists (medical geneticist, neonatologist, neurologist, or developmental pediatrician). The test was ordered by an oncologist and the medical-necessity criteria (one major feature or two or more listed features) are not clearly met; therefore coverage is not supported per the policy.",36950,3282,40232
Case14141,rag,all_correct,iter1,WES,Patient information explicitly states whole exome sequencing (WES) is planned to investigate an underlying genetic etiology.,Yes,"Policy coverage is framed for 'children' with unexplained congenital or neurodevelopmental disorders; the patient is a 7-year-old child, so age meets the policy's child-based eligibility.",No,"Policy requires documentation that the individual has been evaluated by a clinician with expertise in clinical genetics and counseled. The record shows referral by an oncologist and that pre-test counseling was completed, but it does not explicitly document evaluation by a clinician with expertise in clinical genetics.",Yes,"Policy medical indication: WES medically necessary for evaluation of unexplained congenital anomalies in children. The patient has multiple congenital anomalies and prior workup was nondiagnostic, meeting the indication.",Yes,"Policy requires prior testing (eg, chromosomal microarray) to have failed to yield a diagnosis. The patient had chromosomal microarray analysis (CMA) reported as nondiagnostic.",Yes,"Policy guidelines list family history of developmental delay as relevant. The patient has a sibling with global developmental delay, which is a specified relevant family history.",Yes,Policy requires counseling about potential risks and recommends genetic counseling by experienced personnel; the patient completed pre-test genetic counseling and arrangements for post-test counseling/follow-up are documented.,81415,"The requested test is whole exome sequencing; CPT 81415 corresponds to exome sequencing (clinical interpretation/report). The policy document does not specify CPT codes, so this mapping is based on the test requested.",No,"Policy requires ALL criteria: (1) documentation of evaluation by a clinician with expertise in clinical genetics (including family history and phenotype) and counseling, (2) potential for change in management, and (3) prior testing failed to yield diagnosis. While criteria 3 and counseling/family-history elements are met (nondiagnostic CMA, pre-test counseling, sibling with developmental delay), the record does not explicitly document evaluation by a clinician with expertise in clinical genetics nor explicit documentation that testing has potential to change management. Therefore not all required policy criteria are documented, and coverage cannot be confirmed.",14836,2207,17043
Case6747,rag,all_correct,iter1,WGS,Patient information states the child is 'undergoing whole genome sequencing (WGS)' ordered by a medical geneticist; therefore WGS is the test requested.,Yes,Policy age-related language addresses 'children' with congenital anomalies or neurodevelopmental disorders; patient is 12 years old and therefore meets the pediatric (child) age criteria in the policy.,Yes,"Policy criterion 1 requires evaluation by a clinician with expertise in clinical genetics and counseling; the test was ordered by a medical geneticist and pre-test counseling was completed, satisfying ordering/provider requirements.",Yes,"Policy defines medical indications as children with unexplained multiple congenital anomalies or a neurodevelopmental disorder following standard workup; the patient has multiple congenital anomalies and a suspected genetic etiology, meeting the policy's specified medical indication.",Yes,"Policy requires prior standard genetic testing (eg, chromosomal microarray) to have been performed or failed to yield a diagnosis; the record states CMA testing was previously performed and was nondiagnostic, meeting the prior-test requirement.",Yes,"Policy lists family history of developmental delay as relevant; the family reports a sibling with developmental delay, which aligns with the policy's family-history considerations.",Yes,"Policy requires counseling by someone experienced in genetic medicine; patient had pre-test counseling completed and post-test counseling planned, meeting the policy's genetic counseling requirement.",Not Specified,The provided policy document does not list or map specific CPT codes to WGS or WES; no CPT coding guidance is specified in the policy text.,Yes,"Under the policy the evaluation of unexplained congenital anomalies in children may be covered when ALL criteria are met (evaluation by genetics expert and counseling; prior testing nondiagnostic; indication of genetic etiology). The patient is a 12-year-old with multiple congenital anomalies, was evaluated by a medical geneticist, had nondiagnostic CMA, has relevant family history, and counseling was completed — therefore the request meets the policy's stated coverage criteria for pediatric genome/exome testing.",14819,3071,17890
Case811,rag,all_correct,iter1,WES,Patient record explicitly states whole exome sequencing (WES) is being pursued to evaluate an underlying genetic etiology.,Yes,"Policy specifies standard WES may be medically necessary for evaluation of unexplained congenital or neurodevelopmental disorders in children; the patient is a 7-week-old infant (a child), meeting the age-based criterion.",Yes,"Policy requires evaluation by a clinician with expertise in clinical genetics and counseling; patient had pre-test counseling completed with a genetic counselor and family/phenotype documented, satisfying the policy's ordering/provider requirement.",Yes,"Policy medical-necessity criteria: (1) documented genetics evaluation/counseling, (2) potential to change management, and (3) genetic etiology likely despite prior testing (eg, CMA). The patient has early-onset movement disorder, CMA nondiagnostic, positive affected sibling, and counseling—meeting these indications.",Yes,"Policy criterion requires prior genetic testing (eg, chromosomal microarray) unsuccessful before WES for this indication; the patient had CMA previously performed and reported nondiagnostic, satisfying the prior-test requirement.",Yes,"Policy guidelines consider relevant family history (eg, affected first-degree relative or multiple congenital anomalies). The patient has a positive family history in an older sibling with multiple congenital anomalies, which is relevant per policy.",Yes,"Policy requires genetic counseling by an individual with expertise; the patient underwent pre-test counseling with a genetic counselor and has planned post-test follow-up, meeting counseling requirements.",Not Specified,The provided BCBS_FEP policy document does not list or specify CPT billing codes for WES; no CPT mapping is given in the text.,Yes,"Under the policy standard WES may be considered medically necessary for children with unexplained congenital/neurodevelopmental disorders when all criteria are met. The patient is an infant with an unexplained early-onset movement disorder, prior nondiagnostic CMA, relevant family history, and documented genetic counseling—meeting the policy's criteria for coverage.",14871,2111,16982
Case7604,rag,all_correct,iter1,WGS,Patient information explicitly states whole genome sequencing (WGS) has been ordered.,Not Specified,"The policy does not impose an explicit age cutoff for WGS; age-related items in the policy (e.g., diagnoses by 18 years) are feature descriptors rather than strict age exclusions, so no specific age restriction is specified for this neonate.",Yes,"Policy requires WGS to be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the ordering provider is a neurologist, which meets the policy requirement.",Yes,"Policy coverage for WGS requires clinical presentation nonspecific and one of the listed features such as 'multiple congenital anomalies (must affect different organ systems)'. The neonate has multiple congenital anomalies affecting several organ systems and a family member with similar features; WGS was ordered by an approved specialist, so clinical criteria are met.",Not Answerable,"Policy requires that 'Neither CMA nor WES have been performed' for WGS to be covered. Patient record documents prior FISH (nondiagnostic) but does not state whether chromosome microarray (CMA) has or has not been performed, so there is insufficient information to confirm this required prior-test condition.",Yes,"Policy lists 'other first- or second-degree family member(s) with similar clinical features' as a relevant criterion. The patient has an older sibling with multiple congenital anomalies, which meets this family-history criterion.",Not Specified,"The policy states genetic counseling is 'strongly recommended' prior to WES/WGS but does not make counseling an explicit coverage requirement. The patient declined counseling, but counseling is not specified as mandatory for coverage in the policy.",81425,"Policy's applicable CPT codes list 81425 as 'Genome ... sequence analysis' (genome/WGS). The requested test is WGS, so 81425 best corresponds.",Yes,"Based on policy, WGS is medically necessary when results are expected to influence management, ordered by an approved provider, clinical presentation is nonspecific, and features such as multiple congenital anomalies are present. The neonate meets these clinical criteria and the ordering provider requirement; prior testing shows nondiagnostic FISH and no documented CMA or WES (policy requires neither CMA nor WES performed). Therefore, assuming CMA has not been performed (not documented), the request meets the policy coverage rationale for WGS.",36935,2833,39768
Case950,rag,all_correct,iter1,WES,Patient information states 'whole exome sequencing (WES) is being pursued to look for an underlying genetic cause.',Yes,Policy lists 'epileptic encephalopathy with onset before three years of age' as a specific feature meeting WES criteria; patient has epileptic encephalopathy with onset before age 3 (patient currently 38).,Yes,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; patient is being evaluated by a medical geneticist (ordering provider requirement met).",Yes,"Policy medical necessity criteria for WES include (a) nonspecific clinical presentation, (b) ordering by an approved specialist, and (c) presence of a feature such as 'epileptic encephalopathy with onset before three years of age.' Patient has nonspecific unexplained epileptic encephalopathy with onset <3 years and is being worked up by a medical geneticist, satisfying the listed clinical indication.",Not Specified,"Policy does not mandate prior epilepsy multigene panel testing for WES when presentation is nonspecific; it only states that if a specific syndrome is suspected, targeted testing should be done first. Patient has not had prior epilepsy panel but policy does not explicitly require it in this scenario.",No,"Policy lists relevant family history (first-/second-degree relatives with similar features) or consanguinity as supportive criteria. Patient's family history is an uncle with prostate cancer (not a similar neurodevelopmental/epilepsy phenotype) and there is no consanguinity, so relevant family history/consanguinity is not present.",Yes,"Policy states genetic counseling is strongly recommended prior to WES/WGS; patient 'has seen a genetic counselor multiple times' and plans for post-test counseling are in place, meeting counseling expectations.",81415,Policy's Applicable Codes list CPT 81415 for 'Exome; sequence analysis' which corresponds to WES requested for this patient.,Yes,"Per the UnitedHealthcare WES policy, WES is medically necessary when criteria are met: nonspecific presentation, ordered by an approved specialist (medical geneticist), and presence of 'epileptic encephalopathy with onset before three years of age.' Patient meets these criteria (and counseling documented), so WES is covered.",36974,2182,39156
Case17822,rag,all_correct,iter1,WGS,Patient information explicitly states whole genome sequencing (WGS) has been ordered.,Yes,"Policy age-related items (e.g., features diagnosed by 18 years) apply and the patient is 13, which meets the policy age-related criteria for pediatric indications such as multiple congenital anomalies.",Yes,"Policy requires WGS be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the order was placed by a medical geneticist.",Yes,Policy lists 'Multiple congenital anomalies (must affect different organ systems)' as an approved clinical indication for WGS; the patient has multiple congenital anomalies affecting different organ systems.,No,"Policy states WGS is medically necessary only when 'Neither CMA nor WES have been performed'; the patient already had a nondiagnostic CMA, so the policy's prior-test requirement for WGS is not met.",No,"Policy specifies family history/consanguinity as relevant (e.g., 'other first- or second-degree family member(s) with similar clinical features'); the patient’s family history (sibling with short stature) does not represent a first-/second-degree relative with similar multisystem congenital anomalies, so the family-history criterion is not met.",Not Specified,Policy 'strongly recommends' genetic counseling prior to WES/WGS but does not state counseling is a coverage requirement; the patient declined counseling but counseling is not specified as mandatory for coverage in the policy.,81425,"Policy applicable CPT codes list 81425 as 'Genome (e.g., unexplained constitutional or heritable disorder or syndrome); sequence analysis' corresponding to WGS.",No,"Although the patient meets age, provider, and clinical indication criteria (multiple congenital anomalies), the policy requires that WGS be used when 'Neither CMA nor WES have been performed.' The patient has already had CMA (nondiagnostic), so per the policy WGS is not covered.",36947,2482,39429
Case9408,rag,all_correct,iter1,WES,Patient information states the 17-year-old is undergoing whole exome sequencing (WES) at the request of a medical geneticist.,Yes,Policy applies to 'children' with unexplained congenital or neurodevelopmental disorders; the patient is 17 years old (a child/adolescent) and therefore meets the age-based scope of the WES policy.,Yes,"Policy requires evaluation by a clinician with expertise in clinical genetics; the test was requested by a medical geneticist and pre-test counseling was completed, meeting the ordering-provider requirement in the policy.",Yes,"Policy lists neurodevelopmental disorders and examples including persistent seizures as indications. The patient has epileptic encephalopathy with onset before age 3, which matches the policy's defined clinical indications for WES.",Yes,"Policy requires prior standard genetic workup (eg, chromosomal microarray) or that prior testing failed to yield a diagnosis. The patient had CMA previously performed and it was nondiagnostic, satisfying the prior testing requirement.",No,"The policy specifies certain family-history features (eg, developmental delay, inborn errors of metabolism, sudden unexplained death). The provided family history notes a maternal immunologic/hematologic disorder but does not state a listed genetic disorder or that it is a relevant inherited condition; therefore it does not meet the policy's specified family-history criteria.",Yes,"Policy requires counseling by an individual with expertise in genetic medicine. The patient completed pre-test counseling and will have post-test follow-up with a genetic counselor, meeting the counseling requirement.",81415,CPT 81415 corresponds to exome sequencing; the requested test is whole exome sequencing (WES).,Yes,"Under the FEP WES policy, standard WES is medically necessary for children with unexplained neurodevelopmental disorders when all criteria are met: evaluation by a genetics expert (met), prior CMA was nondiagnostic (met), and the presentation (early-onset epileptic encephalopathy/persistent seizures) is a neurodevelopmental phenotype consistent with a genetic etiology (met). Pre-test counseling completed and plans for genetic counselor follow-up further support coverage per policy.",14851,2592,17443
Case3592,rag,all_correct,iter1,CMA,Patient information explicitly states chromosomal microarray (CMA) testing for developmental disorders is being requested.,Yes,"Policy age-related criterion specifies testing be performed on a living child or adult; the patient is a neonate (a living child), so age criterion is met per the policy.",Not Specified,The policy does not specify required ordering provider specialty/type for CMA; it requires pre- and post-test genetic counseling by an appropriate provider but does not mandate a specific ordering provider role.,No,"Policy-defined postnatal indications include DD/ID, ASD, major congenital cardiac anomaly, or multiple congenital anomalies. Neonatal epileptic encephalopathy is not listed as an accepted indication in the policy.",No,"Policy requires 'No previous CMA testing' for diagnostic postnatal CMA; patient has a prior (nondiagnostic) CMA, so the required prior-test condition is not met.",Not Specified,"The policy only addresses specific family-history scenarios (e.g., family history of chromosome rearrangement as an exclusion). The patient's family history (sibling with developmental regression) is not a policy-specified family-history criterion for CMA eligibility.",Yes,"Policy requires pre- and post-test genetic counseling by an appropriate provider. Patient info documents pre-test counseling with a genetic specialist and planned post-test follow-up, satisfying this requirement.",81228,"Policy procedure code list identifies chromosomal microarray (constitutional) as CPT 81228; this best corresponds to the requested CMA and the policy limits reimbursement to one type of microarray (e.g., 81228).",No,"Per the policy, postnatal CMA requires no prior CMA and CMA is reimbursable only once per lifetime. The patient had a prior CMA (nondiagnostic), so the request does not meet the policy's coverage criteria.",10103,2463,12566
Case17929,rag,all_correct,iter1,CMA,Patient information explicitly states 'tumor chromosomal microarray (CMA) testing has been requested'; basis: patient clinical information.,Not Specified,"The UnitedHealthcare CMA policy does not impose a specific age limit for CMA; coverage criteria are indication-based (e.g., ASD, DD/ID, multiple anomalies) rather than age-restricted, so age eligibility is not specified in the policy.",Not Specified,"The policy recommends pre-test counseling and that testing be ordered with informed consent, but it does not specify required ordering provider specialty or explicit provider-type restrictions for ordering CMA; therefore provider requirements are not specified.",No,"UnitedHealthcare policy defines medical necessity for CMA for specific indications (ASD, isolated severe CHD, multiple anomalies not specific to a well-delineated syndrome, DD/ID). The provided facts describe a 7-year-old with a 'major abnormality affecting at least one organ system' but do not document ASD, DD/ID, isolated severe CHD, or multiple anomalies; therefore the patient does not meet the policy's enumerated medical indications.",Not Specified,"The policy allows CMA as a first-tier diagnostic test in many settings and does not universally require prior testing; while some subsections discuss use after normal karyotype in specific contexts (e.g., CHD), the policy does not define a general required prior-test sequence applicable here.",No,"The policy's family-history related coverage language addresses testing of biological parents/siblings of a fetus/child with an abnormal/equivocal CMA result and notes consent issues (non-paternity/consanguinity). The patient's family history of BRCA1/2 pathogenic variants in relatives is not listed as a CMA coverage criterion, so relevant family-history/consanguinity criteria are not met.",Yes,"The policy states pre-test genetic counseling is 'strongly recommended' and that pre-/post-test counseling is essential; the patient has had multiple pretest counseling sessions with a genetic counselor and plans for post-test follow-up, satisfying the counseling requirement per the policy.",81228,UnitedHealthcare policy lists CPT 81228 for constitutional genome-wide CGH microarray analysis (CMA). The requested chromosomal microarray corresponds to 81228 per the policy's applicable codes.,No,"Per the policy, CMA is medically necessary only for the specified indications (ASD, isolated severe CHD, multiple anomalies not specific to a well‑delineated syndrome, DD/ID, certain prenatal indications). The clinical information does not document one of these enumerated indications (only a nonspecific 'major abnormality affecting at least one organ system' and nondiagnostic karyotype), and the policy states CMA is not medically necessary for other conditions; therefore the test is not covered under the policy.",30400,2785,33185
Case12834,rag,all_correct,iter1,CMA,Patient record states chromosomal microarray (CMA) testing was ordered (requisition specifies tumor-type rather than germline).,Not Specified,The Cigna CMA for solid tumors policy (MOL.TS.344.A) contains no age-based eligibility criteria.,Not Specified,The policy requires the rendering laboratory be a qualified provider per the Health Plan but does not specify ordering provider type or specialty (the ordering provider is a developmental pediatrician).,No,"Policy states CMA on solid tumor tissue is medically necessary only if the member has been diagnosed with CNS cancer or soft tissue sarcoma; the patient has a neurodevelopmental disorder, not a CNS cancer or soft tissue sarcoma.",Not Specified,The policy does not define any required prior tests before performing CMA for solid tumors.,Not Specified,"The policy does not include family history or consanguinity criteria for CMA on solid tumors; although the patient has a maternal uncle with a movement disorder, this is not addressed by the policy's eligibility criteria.",Not Specified,"The policy discusses that cytogenomic studies may reveal germline/secondary findings and lab policies should address this, but it does not mandate genetic counseling or specify counseling requirements prior to testing.",81277,The policy's procedure table lists cytogenomic neoplasia microarray analysis with procedure code 81277 for CMA on solid tumors.,No,"Per the policy, CMA on solid tumor tissue is medically necessary only for members diagnosed with CNS cancer or soft tissue sarcoma; the patient (16‑year‑old with neurodevelopmental disorder, no cancer diagnosis) does not meet the coverage criteria.",6182,1149,7331
Case4604,rag,all_correct,iter1,WES,Patient information explicitly states whole exome sequencing (WES) is being requested to evaluate the child's developmental delay/intellectual disability.,Yes,"Policy defines WES as medically necessary for children with unexplained congenital or neurodevelopmental disorders; the patient is a 6-year-old child, which meets the 'children' age criterion in the policy (and aligns with guidelines referring to onset <18 years).",No,"Policy requires documentation that the individual has been evaluated by a clinician with expertise in clinical genetics (including family history and phenotype) and counseled. Patient data documents pre-test counseling by a genetic counselor but does not document an evaluation by a clinician with expertise in clinical genetics, so ordering-provider requirements are not shown to be met.",Yes,"Policy medical indication: unexplained neurodevelopmental disorder in a child after standard workup qualifies. The patient has developmental delay/intellectual disability without a specific syndromic diagnosis after prior standard testing (CMA nondiagnostic), meeting the clinical indication.",Yes,"Policy notes WES is indicated when previous genetic testing (eg, chromosomal microarray analysis) has failed to yield a diagnosis. Patient history documents prior CMA testing was nondiagnostic.",Yes,"Policy guidance lists family history of developmental delay as relevant. The patient has an older sibling with moderate to severe intellectual disability, which is relevant family history.",Yes,"Policy requires genetic counseling; patient information states pre-test counseling was completed with a genetic counselor and plans for post-test follow-up, satisfying the counseling requirement.",Not Specified,The provided BCBS_FEP policy document does not specify or map CPT codes to WES; no CPT guidance appears in the policy text.,No,"Although the patient meets clinical indications (unexplained pediatric neurodevelopmental disorder) and prior CMA was nondiagnostic and genetic counseling was performed, the policy requires documentation that the individual was evaluated by a clinician with expertise in clinical genetics. Such an evaluation is not documented in the patient information; therefore all required policy criteria are not fully met and coverage cannot be confirmed.",14848,2444,17292
Case8661,rag,all_correct,iter1,WGS,Patient information explicitly states whole genome sequencing (WGS) is requested.,Yes,"Policy criteria reference features diagnosed by age 18 (e.g., 'significant hearing or visual impairment diagnosed by 18 years'); patient is 7 years old, which meets the age-related phrasing in the WGS criteria.",Yes,"Policy requires WGS to be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the ordering provider is the child's neurologist, meeting the requirement.",Yes,"WGS criteria require (among other items) clinical history suggesting a genetic cause plus qualifying features. The patient has significant hearing/visual impairment (one listed feature) and a first-degree sibling with early-onset epileptic encephalopathy (relevant family history listed as a qualifying feature), and the clinical presentation is nonspecific—therefore the medical indication in policy is met.",Yes,"Policy for WGS requires that neither CMA nor WES have been performed; patient has only had Fragile X testing (no CMA or WES), satisfying the prior-test requirement.",Yes,"Policy lists 'other first- or second-degree family member(s) with similar clinical features' and 'consanguinity' as relevant features; patient has a sibling with early-onset epileptic encephalopathy, which is relevant family history per the policy.",Not Specified,Policy states genetic counseling is 'strongly recommended' prior to WES/WGS but does not make pre-test counseling an explicit required coverage criterion; thus counseling is recommended but not specified as mandatory for coverage.,81425,"Policy 'Applicable Codes' lists 81425 as 'Genome (e.g., unexplained constitutional or heritable disorder or syndrome); sequence analysis' corresponding to WGS.",Yes,"Per the policy, WGS is medically necessary when criteria are met: (1) neither CMA nor WES performed (true), (2) ordered by an approved provider type (neurologist, true), and (3) clinical history suggests genetic cause with qualifying features (significant childhood hearing/visual impairment plus relevant first-degree family history). Therefore WGS meets coverage criteria.",36963,2788,39751
Case6451,rag,all_correct,iter1,WGS,"Patient information explicitly states ""whole genome sequencing (WGS) is being pursued.""",Yes,"Policy lists qualifying features including ""Hypotonia or hypertonia in infancy"" for WGS; the patient is a 7‑week‑old infant with significant hypotonia, meeting the age‑related (infancy) feature.",Yes,"Policy requires WGS be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the test is ordered by a developmental pediatrician.",Yes,"Policy medical‑necessity criteria for WGS include clinical history suggesting a genetic cause with features such as ""Hypotonia or hypertonia in infancy."" The infant has significant hypotonia, meeting a listed clinical criterion.",Yes,"Policy requires that neither CMA nor WES have been performed prior to WGS. The record indicates a prior karyotype was nondiagnostic but does not indicate CMA or WES were performed, so the prior‑test requirement is satisfied.",Yes,"Policy lists family history/consanguinity among qualifying features. The family reports the mother has a persistent, severe immunologic or hematologic disorder, i.e., relevant family history is present.",Yes,"Policy ""strongly recommends"" genetic counseling prior to WES/WGS. The patient record documents pre‑test counseling was completed and post‑test genetics follow‑up is planned.",81425,"Policy's Applicable Codes lists 81425 as the CPT code for ""Genome (e.g., unexplained constitutional or heritable disorder or syndrome); sequence analysis,"" corresponding to WGS.",Yes,"Based on the policy WGS is medically necessary when criteria are met: ordered by an approved specialist (developmental pediatrician), the infant has a listed qualifying feature (hypotonia in infancy), neither CMA nor WES were performed, and pre‑test counseling occurred. These facts meet the policy coverage criteria for WGS.",36937,3316,40253
Case19255,rag,all_correct,iter1,BRCA1/2,Patient was referred specifically for BRCA1/2 testing to evaluate hereditary breast/ovarian cancer risk (stated in patient info).,Yes,"Policy: ""BRCA1/2 gene testing is proven and medically necessary for individuals with a personal history of Breast Cancer diagnosed at age 65 or younger."" Patient is 38, so meets age criterion.",Not Specified,"Policy strongly recommends pre-test genetic counseling and that evaluations be done by providers familiar with hereditary cancer, but it does not state a strict ordering-provider specialty requirement for coverage. The patient did have pre-test counseling.",Yes,"Policy lists as indications: personal history of breast cancer diagnosed ≤65 and ""Multiple primary Breast Cancers."" Patient has two separate primary breast cancers at age 38, meeting medical necessity criteria.",Not Specified,Policy does not require completion of specific prior diagnostic tests before BRCA1/2 germline testing; prior tumor testing may inform indication but is not a universal prerequisite. The prior FISH result is not listed as a required prior test.,Yes,"Policy considers BRCA-related cancers to include prostate cancer and uses first-degree relatives with prostate cancer as relevant family history. Patient's father has metastatic prostate cancer (first-degree), which is relevant to eligibility.",Not Specified,"Policy: ""Pre-test genetic counseling is strongly recommended,"" but counseling is described as a recommendation rather than an explicit coverage requirement. Patient did complete pre-test counseling with a genetic specialist.",81162,"CPT list in policy: 81162 = BRCA1/BRCA2 full sequence analysis and full duplication/deletion analysis, the comprehensive BRCA1/2 test appropriate for this indication.",Yes,Policy coverage rationale: BRCA1/2 testing is proven and medically necessary for individuals with breast cancer diagnosed ≤65 and for individuals with multiple primary breast cancers. Patient is 38 with two primary breast cancers and relevant family history (father with metastatic prostate cancer); therefore BRCA1/2 testing is covered.,38613,1734,40347
Case2211,rag,all_correct,iter1,BRCA1/2,Patient is referred specifically for BRCA1 and BRCA2 (breast cancer susceptibility) testing per the clinical information; policy lists BRCA1/2 testing as a distinct test.,Yes,"Policy includes age-based criteria for BRCA1/2 (e.g., breast cancer diagnosed ≤65 years) but also allows testing for known familial mutation regardless of age. The patient is 21 (meets age thresholds and is well below 65) and therefore age is not a barrier to coverage.",Not Specified,The policy strongly recommends pre-test genetic counseling and involvement of genetics expertise but does not impose explicit ordering-provider specialty requirements for BRCA1/2 testing as a condition of coverage.,Yes,"Coverage rationale: 'Single gene testing and known mutation testing for familial cancer is proven and medically necessary' and testing is clinically indicated when an individual has a blood relative with a known P/LP variant. Patient has a mother with a known BRCA2 pathogenic variant and multiple affected relatives, meeting policy criteria.",Not Specified,Policy does not require completion of any specific prior tests before BRCA1/2 germline testing in the setting of a known familial BRCA2 pathogenic variant; the patient has no prior genetic testing but policy allows known-mutation/family testing without prior tests.,Yes,"Policy explicitly considers family history relevant (e.g., 'any blood relative with a known P/LP variant' and 'at least two Close Blood Relatives on the same side'); patient reports mother with known BRCA2 PV and at least two additional affected blood relatives on same side.",Yes,"Policy states 'Pre-test genetic counseling is strongly recommended' and emphasizes genetic counseling involvement; patient completed pre-test counseling with a genetic specialist and plans post-test follow-up, meeting the policy's counseling recommendation.",81162,Policy lists CPT 81162 as 'BRCA1/BRCA2 gene analysis; full sequence analysis and full duplication/deletion analysis' — the typical comprehensive BRCA1/2 test requested.,Yes,Under the policy 'Single gene testing and known mutation testing for familial cancer is proven and medically necessary' and an individual with a blood relative with a known BRCA2 pathogenic variant is clinically indicated for testing; patient also has multiple affected relatives and pre-test counseling — therefore covered.,38641,2436,41077
Case18882,rag,all_correct,iter1,WES,Patient information explicitly states whole exome sequencing (WES) is being requested.,Yes,"Policy includes age-related references (e.g., features diagnosed by 18 years) and WES criteria apply to pediatric patients; the patient is 8 years old, which meets the policy age-related criteria for pediatric indications (e.g., congenital anomalies, developmental concerns). (Policy: Coverage Rationale for WES).",Yes,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the ordering/referring provider is a developmental pediatrician. (Policy: Coverage Rationale for WES).",Yes,Policy lists 'multiple congenital anomalies (must affect different organ systems)' as a qualifying clinical indication for WES; the patient has multiple congenital anomalies affecting several organ systems. (Policy: Coverage Rationale for WES).,Not Specified,"The WES coverage criteria do not mandate specific prior tests for postnatal WES in multisystem congenital anomalies (prenatal WES requires prior CMA/karyotype), so no required prior test completion is specified for this indication. (Policy: Coverage Rationale for WES; Prenatal WES section differentiates prenatal requirements).",No,"Policy lists consanguinity or other first-/second-degree family members with similar clinical features as a qualifying feature. The family history provided (mother with long QT syndrome) is a family history of a cardiac condition but is not described as 'similar clinical features' to the proband's multisystem congenital anomalies, and consanguinity is not present. (Policy: Coverage Rationale for WES).",Not Specified,Policy states genetic counseling is 'strongly recommended' prior to WES but does not make pre-test counseling a stated coverage requirement; patient declined pre-test counseling. The policy therefore does not specify counseling as a mandatory criterion for coverage. (Policy: Description of Services; Coverage Rationale).,81415,"Policy's applicable CPT codes list 81415 for 'Exome...; sequence analysis', which corresponds to WES for the proband. (Policy: Applicable Codes table).",Yes,"Per the policy, WES is medically necessary when ordered by an approved provider type and the patient has qualifying features; the 8-year-old patient has multiple congenital anomalies affecting different organ systems and the test is ordered by a developmental pediatrician, meeting WES coverage criteria. (Policy: Coverage Rationale for WES).",36940,2151,39091
Case14408,rag,all_correct,iter1,BRCA1/2,"Patient was referred for BRCA1/2 testing per the clinical information; policy is the Cigna BRCA Analysis guideline, so the requested test is BRCA1/2.",Yes,"Policy requires age ≥18 for BRCA testing (Known familial, AJ founder, Full sequence sections). Patient is 75, which meets the age criterion.",Not Specified,The policy specifies genetic counseling and that the rendering laboratory be qualified but does not specify ordering provider specialty/type requirements; thus ordering provider requirements are not specified in the policy.,Yes,"Under Full Sequence Analysis predisposition testing, the member may be tested if they have a first-degree relative who meets Diagnostic Testing criteria. The patient has a first-degree relative (brother) with breast cancer, which qualifies per the policy.",Yes,"Policy requires no prior full sequencing/known familial mutation for Full Sequence or KFM pathways. Patient has no prior genetic testing, satisfying the prior-testing requirements.",Yes,"Policy criteria use family history; patient has a relevant family history (brother with breast cancer — a first-degree relative), which is directly relevant to eligibility per the guideline.",Yes,"Policy requires pre- and post-test genetic counseling by an appropriate provider. The patient completed pre-test counseling and post-test follow-up with a genetic counselor is planned, meeting the counseling requirement per the policy.",81162,"Policy lists CPT 81162 for BRCA1/2 full sequencing and deletion/duplication analysis combined; since patient meets full sequence criteria and deletion/duplication analysis is often performed concurrently, 81162 is most appropriate per the guideline.",Yes,"Per the BRCA policy, the patient meets coverage criteria: age ≥18, pre-test counseling completed, no prior BRCA testing, and has a first-degree relative (brother) with breast cancer qualifying the member for predisposition/full-sequence BRCA testing. Therefore the test is covered under the guideline.",10244,2167,12411
Case4262,rag,all_correct,iter1,WES,Patient was referred for diagnostic whole exome sequencing (WES) per the clinical information.,Not Specified,Policy uses the term 'children' and references infants but does not state a specific numeric age cutoff; thus no explicit age-based criterion is specified in the policy text.,Yes,"Policy requires documentation that the individual has been evaluated by a clinician with expertise in clinical genetics and counseled; the patient had pre-test genetic counseling and phenotype/family history documented, satisfying the provider requirement.",Yes,"Policy supports WES for children with unexplained congenital anomalies when prior testing failed to yield a diagnosis or a genetic etiology is most likely. The five-week-old has multiple unexplained congenital anomalies and a nondiagnostic prior karyotype, meeting the medical indication criteria.",Not Specified,"Policy gives examples (eg, CMA and/or targeted single-gene testing) but does not mandate specific prior tests as absolute prerequisites; it requires either prior testing failed or genetic etiology is likely despite prior testing.",Yes,"Policy lists family history of BRUE in a sibling as a relevant family-history criterion; the patient has a sibling with a BRUE, which is relevant per the policy.",Yes,Policy requires genetic counseling by an experienced clinician; the clinical information states pre-test genetic counseling was completed and post-test genetics follow-up is planned.,81415,The requested test is whole exome sequencing (WES); CPT 81415 corresponds to exome sequencing services and is the best match among provided codes.,Yes,"Under the policy, standard WES is medically necessary for children with unexplained congenital anomalies when criteria are met. The patient has unexplained multiple congenital anomalies, prior diagnostic testing was nondiagnostic, genetics evaluation/counseling completed, and family history is relevant, so the test is covered per the policy.",14843,1952,16795
Case10363,rag,all_correct,iter1,WGS,Patient information explicitly states whole genome sequencing (WGS) is being pursued.,Not Specified,"The UnitedHealthcare policy does not impose an explicit age cutoff for WGS; age-related items in the policy reference features diagnosed by age (e.g., diagnosed by 18 years) but do not create a strict age eligibility requirement.",No,"Policy requirement: WGS must be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. Patient: WGS was referred/ordered by a general practitioner, which does not meet the specified ordering-provider requirement (policy: 'WGS is ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician').",No,"Policy criteria: WGS is covered when clinical presentation is nonspecific AND one of (e.g., multiple congenital anomalies OR moderate/severe ID/global developmental delay/epileptic encephalopathy) OR clinical history suggests genetic cause AND two or more listed features (which include 'congenital anomaly'). Patient: single congenital anomaly present since birth with no additional listed features documented (no multiple congenital anomalies, no developmental delay, no epilepsy, etc.), so patient does not meet the policy's specified clinical criteria.",Yes,"Policy condition for WGS: 'Neither CMA nor WES have been performed.' Patient: prior testing noted was FISH (nondiagnostic); there is no documentation of prior CMA or WES, satisfying the policy condition that CMA/WES have not been performed.",No,"Policy includes family history/consanguinity as applicable features (e.g., 'other first- or second-degree family member(s) with similar clinical features' and 'consanguinity'). Patient: family history only notes a maternal aunt with pancreatic cancer (not a first/second-degree relative with similar features) and no consanguinity, so relevant family-history criteria are not present.",Not Specified,"Policy states genetic counseling is 'strongly recommended' prior to WGS/WES but does not specify counseling as a mandatory coverage requirement. Patient: has had multiple pre-test genetic counseling sessions, but counseling is not defined as a required coverage criterion in the policy.",81425,"Policy applicable CPT codes: 81425 = 'Genome (e.g., unexplained constitutional or heritable disorder or syndrome); sequence analysis' corresponds to whole genome sequencing requested for this patient.",No,"Per the UnitedHealthcare policy, WGS coverage requires meeting specified clinical criteria and ordering-provider requirements. Although the patient meets the requirement that CMA/WES have not been performed, the patient does not meet the policy's clinical criteria (only a single congenital anomaly documented) and the ordering provider is a general practitioner rather than one of the required specialties; therefore the request does not meet policy coverage criteria.",36961,2465,39426
Case9349,rag,all_correct,iter1,WES,Patient information explicitly states whole exome sequencing (WES) is being pursued.,Yes,"Policy specifies WES may be medically necessary for children; patient is a 5-year-old child, which meets the policy's age group for pediatric WES.",Not Answerable,Policy requires evaluation by a clinician with expertise in clinical genetics. The clinical information documents referral by a cardiologist and pre-test counseling by a genetic counselor but does not explicitly state that a clinician with expertise in clinical genetics evaluated and/or ordered the test.,Yes,"Policy indicates WES may be medically necessary for evaluation of unexplained congenital disorders in children when criteria are met. The patient has an unexplained congenital cardiac anomaly and a family history raising concern for inherited etiology, which meets the policy's clinical indication for consideration of WES.",Yes,"Policy requires prior genetic testing to have failed to yield a diagnosis (eg, CMA or targeted testing). The patient had prior fluorescence in situ hybridization testing that was nondiagnostic, satisfying the 'previous genetic testing failed' element.",Yes,Policy guidelines list sudden unexplained death in a first- or second-degree relative before age 35 as relevant family history. The patient has a paternal uncle with sudden unexplained death before age 35.,Yes,"Policy requires counseling about risks and recommends genetic counseling; the patient completed pre-test counseling with a genetic counselor and has plans for post-test follow-up, meeting the counseling requirement.",81415,The requested test is whole exome sequencing; CPT 81415 corresponds to exome sequencing in the provided options.,Yes,"Under the policy WES may be medically necessary for children with unexplained congenital disorders when criteria are met. The patient is a child with an unexplained congenital cardiac anomaly, has prior nondiagnostic genetic testing (FISH), has relevant family history (sudden death <35), and genetic counseling was completed—together these facts align with the policy's medical necessity criteria.",14843,3450,18293
Case1428,rag,all_correct,iter1,WGS,Patient information explicitly states whole genome sequencing (WGS) has been ordered.,Not Specified,"The policy does not impose a general age cutoff for WGS; age-specific items (e.g., ID diagnosed by 18, onset windows) are phenotype-related but there is no standalone age-based eligibility that would exclude or include a 3-week-old.",Yes,"Policy requires WGS be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The patient is being evaluated by a medical geneticist who ordered WGS, meeting the provider requirement (Policy: 'WGS is ordered by a medical geneticist...').",No,"Policy requires either (A) the proband have one major feature (e.g., multiple congenital anomalies affecting different organ systems, moderate–severe ID by 18, global DD, early epileptic encephalopathy) or (B) two or more listed features (e.g., congenital anomaly plus another). The infant has a single congenital anomaly (Hirschsprung) and a family history of a sibling with severe ID, but does not meet the policy's required one-major-feature or two-or-more-secondary-features thresholds for WGS (Policy: 'one of the following: ... or ... two or more of the following').",Yes,"Policy specifies WGS is proven medically necessary when 'Neither CMA nor WES have been performed.' The clinical information notes only Fragile X testing was done and no CMA or WES, so the prior-test requirement (absence of CMA/WES) is met.",Yes,The patient has a first-degree relative (older sibling) with severe intellectual disability diagnosed by age 18. The policy lists family history/consanguinity as relevant features (Policy lists 'Other first- or second-degree family member(s) with similar clinical features' and includes family history among features considered).,Not Specified,"The policy states genetic counseling is 'strongly recommended' prior to WES/WGS but does not make documented pre-test counseling a coverage requirement. The record indicates no documented pre-test counseling, but counseling is not specified as a mandatory coverage criterion in the policy.",81425,"Policy's applicable CPT codes list 81425 as 'Genome (e.g., unexplained constitutional or heritable disorder or syndrome); sequence analysis' corresponding to whole genome sequencing.",No,"Although provider type (medical geneticist) and prior-test status (no CMA/WES performed) meet policy requirements, the patient does not meet the policy's defined medical necessity phenotype criteria for WGS (no major feature or two or more secondary features present). Therefore WGS is not supported as medically necessary per the policy.",36931,3664,40595
Case3359,rag,all_correct,iter1,WES,Patient info states 'Whole exome sequencing (WES) is being requested' for evaluation of developmental concerns; matches WES in the policy.,Yes,"Policy includes age-related criterion of global developmental delay with onset prior to 5 years as an indication for WES. The patient is 4 years old, which meets the policy's age-related criterion for GDD/onset <5 years.",Yes,"Policy requires WES to be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The ordering provider is a developmental pediatrician, meeting the policy requirement.",Yes,"Policy requires nonspecific presentation plus either (A) one major feature (e.g., GDD) or (B) two or more listed features. The child has nonspecific developmental concerns with significant hypotonia and a first-degree relative (sibling) with developmental delay — two listed features in the policy — meeting the medical indication.",Not Specified,"The WES coverage criteria do not mandate completion of specific prior tests (except targeted testing if a specific syndrome is suspected). Although the patient had a nondiagnostic CMA, the policy does not require CMA prior to WES for this indication.",Yes,"Policy lists 'Other first- or second-degree family member(s) with similar clinical features' as a relevant criterion. The patient has a sibling with developmental delay (first-degree), which is relevant per the policy.",Not Specified,"The policy states genetic counseling is 'strongly recommended' prior to WES/WGS but does not list pre-test counseling as a mandatory coverage requirement. Patient had pre-test counseling, but counseling is not a stated coverage criterion.",81415,"Policy applicable CPT codes list 81415 for exome (sequence analysis), which corresponds to the requested WES.",Yes,"Per the policy, WES is medically necessary when ordered by an allowed provider and clinical criteria are met. The test is ordered by a developmental pediatrician, the child has nonspecific developmental presentation with hypotonia and a first-degree relative with similar features (two policy-listed features), and age is appropriate — therefore coverage criteria are satisfied.",36955,2592,39547
Case9978,rag,all_correct,iter1,WES,Patient information states the 53-year-old is undergoing whole exome sequencing (WES) at the request of the neurologist.,Yes,"Policy age-related criterion is based on onset for certain features; WES coverage criteria explicitly list 'epileptic encephalopathy with onset before three years of age.' Patient’s encephalopathy began before age three, meeting that age-related criterion.",Yes,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The ordering provider is a neurologist, which satisfies the policy requirement.",Yes,"Policy lists epileptic encephalopathy with onset before age three as a specific clinical indication for WES. The patient has epileptic encephalopathy with onset before age three, so meets the medical indication.",Not Specified,Policy only specifies prior/alternate testing if a specific genetic syndrome is suspected (targeted single gene/panel first). Patient history does not indicate a specific syndrome requiring prior targeted testing; Fragile X was done but policy does not mandate additional specific prior tests for this indication.,Yes,"The policy includes family history/related affected first- or second-degree relatives as a relevant feature. The patient has a brother with an inborn error of metabolism (a first-degree relative with a genetic disorder), satisfying the family-history-related criterion in the policy.",Yes,"Policy states genetic counseling is strongly recommended prior to WES/WGS. Patient completed pre-test counseling with a genetic counselor and plans post-test follow-up, meeting the counseling recommendation.",81415,Applicable Codes section of the policy lists 81415 as the CPT code for exome sequence analysis (WES) for unexplained constitutional or heritable disorder or syndrome.,Yes,"Based on policy, WES is proven and medically necessary when (a) ordered by an appropriate specialist (neurologist), (b) clinical presentation includes epileptic encephalopathy with onset before age three (met), and (c) counseling provided (met). These criteria are satisfied by the patient’s facts, so the test is covered per the policy.",36935,2777,39712
Case22,rag,all_correct,iter1,BRCA1/2,Patient information explicitly states he is undergoing BRCA1/2 testing to evaluate for hereditary predisposition.,Yes,"Policy specifies testing in minors is investigational; the patient is 18 (an adult). Policy age restriction for minors does not apply, so age-based criteria are satisfied (policy: ""Genetic testing in minors ... is considered investigational"").",Not Specified,"The policy requires testing be performed in a setting with suitably trained providers and access to CLIA labs and recommends genetic counseling, but it does not specify a required ordering provider specialty. Therefore explicit ordering-provider specialty requirements are not specified.",Yes,"Policy lists ""Personal history of metastatic or intraductal/cribriform histology prostate cancer at any age"" as a medical indication for BRCA1/2 testing; the patient has metastatic, intraductal/cribriform high-risk prostate cancer, so he meets the clinical criterion.",Not Specified,The policy does not mandate completion of specific prior tests before BRCA1/2 testing in this scenario. Prior chromosomal microarray (CMA) is noted in the patient record but the policy does not require CMA or other prior tests.,Yes,"Policy considers family history of metastatic or intraductal/cribriform prostate cancer in close relatives relevant. The patient’s father had metastatic high-risk prostate cancer with intraductal/cribriform features, which is a relevant family history per policy.",Yes,"Policy requires appropriate pre- and post-test genetic counseling by experienced providers. The patient completed pre-test counseling and will return for post-test follow-up with a genetic counselor, meeting the counseling requirement.",Not Specified,"The provided BCBS_FEP policy text does not specify CPT or billing codes for BRCA1/2 testing, so no specific CPT code can be determined from the policy.",Yes,"Under the BCBS_FEP policy, germline BRCA1/2 testing ""may be considered medically necessary"" for individuals with a personal history of metastatic or intraductal/cribriform prostate cancer at any age. The patient meets that indication, is an adult, has required counseling, and therefore the test is covered per policy.",18975,2161,21136
Case5605,rag,all_correct,iter1,WGS,Patient information states the patient was referred for whole genome sequencing (WGS).,No,"Policy allows rapid WGS for critically ill infants (NICU/PICU) but states 'whole genome sequencing is considered investigational for the diagnosis of genetic disorders in all other situations.' The patient is an 11-year-old non-critically ill child, so the age/clinical-status criterion for medically necessary WGS is not met (policy basis).",Yes,"Policy requires documentation that the individual has been evaluated by a clinician with expertise in clinical genetics and counseled. The patient had pre-test counseling completed with a genetic specialist, satisfying the policy's provider/evaluation requirement.",No,"Policy medical indications for medically necessary genomic testing limit WGS to rapid testing in critically ill infants; for standard testing, WES is the covered modality for children with unexplained congenital anomalies. The patient is an 11-year-old non-critically ill child with a congenital cardiac anomaly, which does not meet the policy's narrow medical indication for WGS.",Not Specified,"The policy explicitly cites prior testing (eg, CMA) as part of criteria for medically necessary WES, but does not define specific required prior tests for WGS (which is considered investigational in most situations). The patient did have a nondiagnostic CMA, but the policy does not specify prior-test requirements for WGS.",No,"Policy lists specific family-history examples relevant to genomic testing (eg, arrhythmia, sudden unexplained death, developmental delay). The patient's only noted family history is a maternal aunt with pancreatic cancer, which is not among the policy-specified relevant family-history criteria.",Yes,"Policy states genetic counseling should be performed by an individual with experience and expertise; the patient had pre-test counseling with a genetic specialist, meeting the counseling requirement.",81425,"The requested test is whole genome sequencing; CPT 81425 corresponds to whole genome sequencing (genomic sequencing, large-scale/genome). The policy document does not list CPTs, but 81425 best matches WGS.",No,"Per the policy statement, 'whole genome sequencing is considered investigational for the diagnosis of genetic disorders in all other situations.' The patient is an 11-year-old non-critically ill child with a congenital cardiac anomaly; therefore WGS is not covered under this policy.",14822,2697,17519
Case19162,rag,all_correct,iter1,WGS,Patient clinical information explicitly states testing was referred for whole genome sequencing (WGS).,Yes,"Policy includes age-based language (infants/children) for WGS when done rapidly in critically ill infants; the patient is a neonate (an infant), so the patient meets the policy's age descriptor for infant/child.",Yes,"Policy requires evaluation by a clinician with expertise in clinical genetics and counseling; the patient was referred by a medical geneticist and had pre-test counseling by a genetic counselor, meeting ordering/provider requirements in policy.",No,"Policy limits medically necessary WGS to rapid WGS for critically ill infants in NICU/PICU meeting specified criteria. The record does not state the neonate is critically ill or in NICU/PICU, so the patient does not meet the specific medical indication for WGS per the policy.",Not Specified,"The policy specifies prior genetic testing requirements for standard WES (eg, CMA/targeted testing) but does not specify explicit prior-test requirements for WGS outside the rapid critically ill context; the policy text does not clearly define required prior tests for the requested (non-rapid) WGS.",Yes,"Policy lists family history of an inborn error of metabolism as relevant; the patient has a sibling with an inborn error of metabolism, satisfying the family-history criterion.",Yes,"Policy requires genetic counseling as part of evaluation; the patient completed pre-test counseling with a genetic counselor, meeting the counseling requirement.",Not Specified,The provided BCBS_FEP policy document does not specify CPT/billing codes for WGS or map the requested test to a CPT code; therefore a specific CPT cannot be determined from the policy text.,No,"Per the policy, WGS is only considered medically necessary as a rapid test for critically ill infants in NICU/PICU meeting specific criteria; standard (non-rapid) WGS in other situations is considered investigational. The record does not indicate the neonate is critically ill/in NICU, so the requested WGS is not covered under this policy.",14852,3473,18325
Case15834,rag,all_correct,iter1,WES,Patient information explicitly states 'whole exome sequencing (WES) has been ordered.',Not Specified,"The policy does not impose a single overall age cutoff for WES; age limits are only specified for certain clinical features (e.g., ID diagnosed by age 18). The infant’s age alone is not an explicit eligibility requirement in the WES coverage criteria.",Not Answerable,"Policy requires WES to be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The patient info states referral by a PCP and that pre-test counseling occurred with a genetic specialist, but it does not explicitly state which clinician placed the WES order, so insufficient information to determine compliance with ordering-provider requirement.",No,"Policy coverage requires either (A) clinical history strongly suggesting a genetic cause plus one primary feature (e.g., global developmental delay, multiple congenital anomalies) or (B) clinical history strongly suggesting a genetic cause plus two or more secondary features (the secondary list includes ASD among many others). The infant has concern for ASD only (one secondary feature) and no documented additional qualifying features (family history of an aunt with a congenital anomaly is present but is not documented as a similar phenotype in a first/second-degree relative). Thus the defined medical-indication criteria in the policy are not met.",Not Specified,"The policy does not mandate a specific prior test (e.g., CMA) universally before WES for neurodevelopmental indications; it only advises targeted testing first when a specific syndrome is suspected. The patient had prior Fragile X testing (nondiagnostic), but the policy does not specify that particular prior testing is required for WES in this scenario.",Yes,"The policy lists 'Other first- or second-degree family member(s) with similar clinical features' and 'consanguinity' among features relevant to WES eligibility. The patient has a family history (maternal aunt with a congenital anomaly), i.e., a second-degree relative, which is family-history information relevant to the policy criteria.",Not Specified,"The policy states genetic counseling is 'strongly recommended' prior to WES/WGS but does not list pre-test counseling as an explicit required coverage criterion. The patient did have pre-test counseling with a genetic specialist, but counseling is not a formal required condition for coverage per the policy.",81415,"Policy 'Applicable Codes' maps exome sequence analysis to CPT 81415 (Exome; sequence analysis), which corresponds to the requested WES.",No,"Per the UnitedHealthcare WES coverage rationale, WES is covered only when the patient meets the specified clinical criteria (e.g., one primary qualifying feature or two or more secondary features and ordered by specified specialists). The infant has only concern for ASD (one secondary feature) and a remote family history (a maternal aunt with a congenital anomaly) but does not meet the policy-defined threshold of clinical features; additionally, the ordering provider type is not documented. Based on the policy criteria and the supplied patient facts, coverage criteria are not met.",36936,3162,40098
Case13,rag,all_correct,iter1,WES,Patient was referred for whole exome sequencing (WES) after nondiagnostic karyotype; the clinical note explicitly states WES is being ordered. (Based on patient information.),Yes,"Policy specifies WES may be medically necessary for children (including infants/newborns) with unexplained congenital anomalies; the patient is a newborn with multiple congenital anomalies, satisfying the age context in the policy. (Based on policy: WES for children with unexplained congenital disorders.)",Not Answerable,"Policy requires documentation that the individual has been evaluated by a clinician with expertise in clinical genetics. The patient info lists evaluation by a general pediatrician and that pre-test genetic counseling was completed, but it does not state whether a clinician with expertise in clinical genetics evaluated the infant or whether the ordering provider meets the policy requirement. (Based on policy criterion 1 and available patient facts.)",Yes,"Policy defines an indication of unexplained congenital anomalies in children for WES. The patient has multiple congenital anomalies not fitting a well-delineated syndrome and no diagnosis after karyotype, matching the clinical indication. (Based on policy: WES for unexplained congenital disorders.)",No,"Policy criterion requires prior genetic testing (eg, chromosomal microarray analysis and/or targeted single-gene testing) or failed prior testing per policy. The patient had a nondiagnostic karyotype but there is no documentation of CMA or targeted single-gene testing, so required prior testing per policy has not been shown. (Based on policy examples for prior testing and patient facts.)",Yes,"Policy lists family history of developmental delay as a relevant family-history criterion. The patient has a sibling with unexplained developmental regression, meeting the policy's family-history relevance. (Based on policy family-history examples and patient facts.)",Yes,"Policy requires genetic counseling by an experienced individual and documentation of counseling as part of criterion 1. The patient information states pre-test genetic counseling was completed and post-test follow-up is planned, meeting the counseling requirement as documented. (Based on policy genetic counseling requirement and patient facts.)",Not Specified,The provided BCBS_FEP policy document does not specify CPT codes for WES. No CPT mapping is included in the policy text. (Based on absence of CPT guidance in the policy.),No,"Although the patient meets the clinical indication (unexplained congenital anomalies) and age and has documented pre-test counseling and relevant family history, the policy requires ALL criteria be met (including documented evaluation by a clinician with expertise in clinical genetics and prior appropriate genetic testing such as CMA/targeted testing). Those specific requirements are not documented in the patient information (no documentation of genetics clinician evaluation and no CMA/targeted testing documented), so policy conditions for coverage are not fully satisfied. (Based on policy statement requiring ALL criteria and the available patient facts.)",14829,2610,17439
Case16487,rag,all_correct,iter1,WES,Patient information states whole exome sequencing (WES) has been ordered.,Not Specified,"The policy does not impose a general age cutoff for WES; age-specific references exist for certain listed features (e.g., ID diagnosed by 18 years) but no universal age eligibility criterion that would exclude a newborn is specified.",No,"Policy requires WES to be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the ordering provider here is an oncologist, which does not meet the specified requirement (Coverage Rationale).",No,"Policy coverage requires that clinical history strongly suggest a genetic cause plus specific listed features (one major or two+ minor features). The newborn has BRUE and a maternal aunt with an immunologic/hematologic disorder, but the patient does not meet any of the policy-defined features (e.g., persistent/severe immunologic disorder in the proband, congenital anomalies, global DD, epilepsy, or two+ listed minor features). Thus defined clinical indications are not met.",Not Specified,"The policy conditionally recommends targeted single-gene/panel testing when a specific syndrome is suspected and specifies prenatal CMA/karyotype requirements for prenatal WES, but it does not mandate specific prior tests for postnatal WES in this scenario. The patient had nondiagnostic FISH, which the policy does not list as a required prior test.",No,"The policy lists family history (other first- or second-degree family members with similar clinical features) and consanguinity as relevant features. Although the patient has a maternal aunt with a severe immunologic/hematologic disorder (a second-degree relative), there is no documentation that the aunt's features are similar to the proband's presentation, so the policy's family-history criterion is not satisfied.",Yes,"Policy states genetic counseling is strongly recommended prior to WES/WGS. Patient information documents that pre-test counseling was completed and post-test genetic follow-up is planned, meeting the counseling recommendation.",81415,Policy's Applicable Codes lists 81415 for exome sequence analysis (WES); this best corresponds to the ordered whole exome sequencing.,No,"Per policy, coverage requires both meeting clinical indication criteria and that WES be ordered by a listed specialist. The patient does not meet the policy-defined clinical indication and the ordering provider (oncologist) is not one of the authorized specialties, so WES is not covered under the policy.",36947,2912,39859
Case3677,rag,all_correct,iter1,BRCA1/2,Patient information states she is 'undergoing BRCA1/2 testing.' Coverage decision will therefore consider BRCA1/2 testing specifically.,Yes,"Policy: 'BRCA1/2 gene testing is proven and medically necessary for individuals with a personal history of Breast Cancer diagnosed at age 65 or younger.' Patient is 46 with prior breast cancer, meeting the age criterion.",Not Specified,The policy recommends pre-test genetic counseling and genetic expertise but does not state a specific required ordering provider specialty or credential as a coverage condition for BRCA1/2 testing.,Yes,"Policy medical indication: personal history of breast cancer diagnosed ≤65 years is a defined indication for BRCA1/2 testing; patient has a personal history of breast cancer and is 46, meeting this criterion.",Not Specified,"The policy does not require prior testing (e.g., CMA) before BRCA1/2 testing; it recommends counseling and consideration of testing of affected relatives first when appropriate, but no prior test completion is mandated.",Yes,"Policy lists family history criteria (e.g., first- or second-degree relative with pancreatic cancer is relevant to BRCA-related cancers). Patient has a mother with pancreatic cancer and additional affected maternal relatives, satisfying family-history criteria.",Not Specified,Policy states 'Pre-test genetic counseling is strongly recommended' but does not make genetic counseling a mandatory coverage requirement; patient did complete pre-test counseling (meets the recommendation but the policy does not require it as a condition).,81162,"Applicable Codes section: CPT 81162 = BRCA1/BRCA2 full sequence analysis and full duplication/deletion analysis, which corresponds to comprehensive BRCA1/2 testing described.",Yes,"Based on policy coverage rationale BRCA1/2 testing is medically necessary for individuals with personal history of breast cancer diagnosed ≤65 and given the patient's age (46), personal breast cancer history, and relevant family history (first-degree relative with pancreatic cancer), the test meets the policy's coverage criteria.",38638,1675,40313
Case3474,rag,all_correct,iter1,WGS,Patient information explicitly states whole genome sequencing (WGS) is being ordered.,Not Specified,"The UHC policy does not impose an overall age cutoff for WGS; age-limited language in the policy applies to specific features (e.g., ID diagnosed by age 18) but no blanket age restriction is specified for WGS and the patient is 5 years old.",Yes,"Policy requires WGS be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the patient was evaluated and WGS is being ordered by a medical geneticist, meeting ordering-provider criteria (policy: Coverage Rationale).",Yes,"Policy requires clinical history strongly suggesting a genetic cause plus qualifying features. The patient has a congenital anomaly (choanal atresia) and a first-degree relative with developmental delay, and the clinical presentation is not described as a well-defined single-gene syndrome; together with the medical geneticist ordering WGS and no prior CMA/WES (see Q4), these facts meet the policy's clinical indications for WGS.",Yes,"UHC WGS coverage criterion specifies 'neither CMA nor WES have been performed.' Patient history documents prior karyotype only and does not report prior CMA or WES, so required prior tests (absence of CMA/WES) are satisfied for WGS per policy.",Yes,"Policy lists family history (other first- or second-degree family member(s) with similar clinical features) as a qualifying feature; the patient has an older sibling with developmental delay, which constitutes relevant family history under the policy.",Yes,"Policy states genetic counseling is strongly recommended prior to WGS. Patient information documents pre-test genetic counseling completed on multiple occasions with plans for post-test follow-up, meeting the counseling recommendation in the policy.",81425,Policy's Applicable Codes list maps whole genome sequence analysis to CPT code 81425 (‘Genome; sequence analysis’).,Yes,"Under the UHC policy WGS is medically necessary when criteria are met: WGS ordered by a medical geneticist (met), neither CMA nor WES performed (met), clinical history suggests a genetic cause with qualifying features (congenital anomaly + relevant family history) and presentation is nonspecific (met). Therefore WGS meets the policy's coverage rationale and is covered.",36944,3461,40405
Case15938,rag,all_correct,iter1,WGS,Patient information states whole-genome sequencing (WGS) is being considered to identify a genetic cholestatic/metabolic etiology.,Not Specified,"The policy does not impose an overall age exclusion for WGS; age-based items are present for specific features (e.g., ID diagnosed by 18) but there is no explicit age cutoff that would exclude a one-week-old neonate.",Yes,"Policy requires WGS be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the ordering provider is a neonatologist, which meets the policy requirement.",Yes,"Policy requires: (1) clinical presentation nonspecific and (2) ordered by an approved provider and (3) presence of listed features. The neonate has suspected genetic cholestatic/metabolic disease (nonspecific presentation), is ordered by a neonatologist, and has laboratory abnormality suggestive of an IEM (conjugated hyperbilirubinemia) plus a first-degree relative with unexplained developmental regression—meeting the feature requirements in the policy for WGS.",Yes,"Policy condition for WGS is that neither CMA nor WES have been performed. The patient had a nondiagnostic karyotype only; no CMA or WES was performed, satisfying the policy's prior-testing requirement for WGS.",Yes,Policy lists relevant family history (other first- or second-degree family member(s) with similar clinical features / unexplained developmental regression) as a qualifying feature; the patient has a sibling with unexplained developmental regression.,Not Specified,The policy states genetic counseling is strongly recommended prior to WES/WGS but does not make pretest genetic counseling an explicit required coverage criterion; the chart documents no pretest counseling but the policy does not mandate it as a coverage requirement.,81425,Policy's applicable CPT codes list 81425 for genome (whole genome) sequence analysis; the requested test is WGS.,Yes,"Under the UnitedHealthcare WES/WGS policy, WGS is medically necessary when clinical presentation is nonspecific, ordered by an approved provider (neonatologist), neither CMA nor WES have been performed (only karyotype done), and qualifying features are present (laboratory abnormality suggestive of an IEM and relevant family history). The patient's facts meet these policy criteria, supporting coverage.",36949,3789,40738
Case4067,rag,all_correct,iter1,WES,"Patient information explicitly states ""whole exome sequencing (WES) has been ordered.""",No,"The policy includes age-specific criteria (e.g., global developmental delay onset prior to 5 years; intellectual disability diagnosed by 18 years; hypotonia specified as ""in infancy""). The patient is 5 years old with hypotonia but does not clearly meet the policy's age‑specific feature definitions (hypotonia in infancy or documented GDD onset <5), so age‑related criteria are not met per policy.",Yes,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The test was ordered by a developmental pediatrician, which meets the provider requirement.",No,"Policy coverage requires either (A) one of the first-tier features (e.g., global developmental delay, ID diagnosed by 18) or (B) two or more features from the second list (e.g., congenital anomaly, hypotonia in infancy, neuromuscular disorder, family members with similar features). The record documents only significant hypotonia and a nondiagnostic karyotype; hypotonia alone (and not specified as infancy) does not satisfy the defined clinical criteria.",Not Specified,"The policy does not mandate prior CMA/karyotype for outpatient WES (prenatal WES has specific prior-test requirements). Although the patient had a nondiagnostic karyotype, the policy does not specify a required prior test sequence for non‑prenatal WES beyond targeted testing if a specific syndrome is suspected.",No,"Policy specifies family history qualifying criteria as consanguinity or first/second‑degree family members with similar clinical features. The patient has a paternal uncle with sudden unexplained death (a second‑degree relative) but no documentation of a similar clinical phenotype, so the documented family history does not meet the policy's specified family-history criterion.",Not Specified,"The policy states genetic counseling is ""strongly recommended"" prior to WES/WGS but does not make counseling an absolute coverage requirement; no genetic counseling information is provided in the patient data.",81415,"Applicable codes in the policy list CPT 81415 for exome (sequence analysis), which corresponds to WES.",No,"Although ordering provider and coding align with policy, the patient does not meet the policy's specified medical indication criteria for outpatient WES (policy requires either one of the primary features such as global developmental delay/ID or two or more features from the secondary list; the record documents only hypotonia and nondiagnostic karyotype). Therefore, under the policy the test is not covered.",36932,3459,40391
Case11514,rag,all_correct,iter1,WES,Patient information explicitly states whole exome sequencing (WES) has been requested to investigate a genetic cause of cholestatic liver disease.,Not Specified,"The policy does not impose a general age limit for WES; age-related items in the criteria reference features 'diagnosed by 18 years' but no blanket age exclusion is stated. The patient is 10, which is not disqualifying per policy.",No,"Policy requires WES to be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The test was ordered by the patient's oncologist, which does not meet the specified ordering-provider requirement.",No,"Policy medical necessity requires either (A) one of a specific short list of major features or (B) two or more listed features (which include 'laboratory abnormalities suggestive of an IEM'). The patient has a laboratory abnormality suggestive of IEM (conjugated hyperbilirubinemia) but lacks a second qualifying feature from the policy list, so the defined clinical criteria are not met.",Not Specified,"The WES coverage criteria do not mandate prior testing (e.g., CMA) as a universal requirement; policy discusses prior CMA in the prenatal context and targeted testing if a specific syndrome is suspected, but does not state a required prior test for outpatient WES. (The patient did have a nondiagnostic CMA, but the policy does not make CMA universally required before WES.)",No,"Policy specifies family-history criteria as 'other first- or second-degree family member(s) with similar clinical features' or consanguinity. The patient’s reported affected relative is a cousin (not first- or second-degree as defined), so the family-history criterion as specified is not met.",Not Specified,"Policy states genetic counseling is 'strongly recommended' prior to WES/WGS but does not make pre-test counseling a mandatory coverage requirement. There is no documented counseling for this patient, but the policy does not require it as a condition of coverage.",81415,"The applicable CPT code for an exome (sequence analysis) per the policy is 81415 (Exome; sequence analysis), which corresponds to WES.",No,"Coverage criteria require (among other things) that WES be ordered by an authorized provider type and that specified clinical features be met. Here the ordering provider is an oncologist (not an allowed ordering specialty) and the patient does not meet the policy-defined clinical criteria (only one qualifying feature: laboratory abnormality suggestive of an IEM). Based on the policy, the request is not covered.",36969,2433,39402
Case11981,rag,all_correct,iter1,WGS,Patient information explicitly states 'Whole genome sequencing (WGS) is being requested' — test requested is WGS.,Yes,"Policy age-related criteria (e.g., features diagnosed by age 18) apply; patient is 9 years old which meets the age-related criteria in the WGS/WES coverage rationale (many qualifying features are permitted through age 18).",Not Answerable,"Policy requires WGS be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. Patient record states WGS was requested 'after pre-test discussion with a genetic specialist' and that the patient was 'referred by neurology,' but it does not explicitly state which provider placed the order, so provider eligibility cannot be confirmed from the provided information.",Yes,"Policy permits WGS when clinical history strongly suggests a genetic cause and features such as 'hypotonia or hypertonia in infancy' or other neurologic abnormalities are present. Patient had abnormal muscle tone noted in infancy and ongoing motor/developmental concerns, which meet the policy's clinical indication criteria.",Not Answerable,"Policy condition for WGS states 'Neither CMA nor WES have been performed.' The record documents prior fragile X testing only; it does not state whether chromosome microarray (CMA) has been performed, so it cannot be confirmed from the provided information that required prior-test conditions are met.",Yes,"Policy lists family history (first- or second-degree relatives with similar features) and 'persistent and severe immunologic or hematologic disorder' as qualifying considerations. Patient has a maternal uncle with a persistent severe immunologic disorder (a second-degree relative), which is relevant under the policy.",Not Specified,"Policy states genetic counseling is 'strongly recommended' prior to WES/WGS but does not make counseling a stated coverage requirement. Patient had a 'pre-test discussion with a genetic specialist,' but the policy does not require counseling as a formal coverage criterion.",81425,"Policy's applicable CPT listing maps whole genome sequence analysis to CPT code 81425 ('Genome ...; sequence analysis'), which corresponds to the requested WGS.",Yes,"Based on the policy, WGS is medically necessary when: (1) clinical presentation is nonspecific and suggests a genetic cause, (2) qualifying features are present, and (3) neither CMA nor WES have been performed. The patient has abnormal muscle tone since infancy (qualifying feature: hypotonia/hypertonia in infancy and neurologic abnormality), is age 9 (within policy age considerations), and no CMA/WES are documented (only fragile X was done). Also a genetic specialist was involved in pre-test discussion. However, coverage approval is contingent on confirmation of the ordering provider meeting the policy-required specialties and verification that CMA has not been performed; based on the provided information the clinical criteria are met and WGS would be covered per the policy.",36954,3452,40406
Case7682,rag,all_correct,iter1,WES,Patient clinical info states 'whole exome sequencing (WES) is being requested' — directly names WES.,Yes,"Policy includes age-based items (e.g., features diagnosed by 18 years) and has no upper age exclusion for multiple congenital anomalies; patient is 9 years old and therefore meets the policy age-related criteria (e.g., criteria that must be met by age 18).",Yes,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the patient was referred by a developmental pediatrician who is requesting WES.",Yes,Policy lists 'multiple congenital anomalies (must affect different organ systems)' as an explicit qualifying indication for WES; the patient has multiple congenital abnormalities affecting different organ systems and family history of developmental delay.,Not Specified,Policy does not mandate prior tests before postnatal WES except when a specific syndrome is suspected (targeted testing first) or for prenatal WES (CMA/karyotype required); no general prior-test requirement for this postnatal WES is specified.,Yes,Policy lists 'other first- or second-degree family member(s) with similar clinical features' as a qualifying feature; the patient has a sibling with developmental delay.,Not Specified,"Policy states genetic counseling is 'strongly recommended' prior to WES but does not make counseling a formal coverage requirement; patient did receive pre-test counseling, but counseling is not specified as mandatory for coverage.",81415,Applicable CPT codes in the policy list 81415 as 'Exome; sequence analysis' which corresponds to WES requested for this patient.,Yes,"Per the UnitedHealthcare WES policy the patient meets all stated coverage criteria: WES is ordered by an allowed provider type (developmental pediatrician), the clinical presentation is nonspecific with multiple congenital anomalies affecting different organ systems (an explicit qualifying indication), there is relevant family history, prior karyotype was nondiagnostic, and pre-test genetic counseling was completed. These facts align with the policy's medical necessity criteria for WES.",36935,2584,39519
Case3494,rag,all_correct,iter1,WES,Patient information states whole exome sequencing (WES) is being requested for diagnostic clarification.,Yes,"Policy requires member <21 years for ES; the patient is a six-week-old infant, which meets the <21 years age criterion (Cigna Exome Sequencing criteria).",Not Specified,The policy does not specify ordering-provider specialty or type requirements for ES; it only requires the rendering laboratory be a qualified provider per Health Plan policy.,Yes,"Policy requires a genetic etiology likely based on listed presentations. The patient has a congenital abnormality affecting at least one organ system (meets 'major abnormality affecting at minimum a single organ system') and concern for an evolving complex neurodevelopmental disorder (meets 'symptoms of a complex neurodevelopmental disorder'), satisfying TWO of the listed clinical features in the guideline.",Not Specified,"The guideline requires documentation of prior testing in the clinical letter but does not mandate specific prior tests (except prior ES/GS must not have been performed). The patient has had no prior genetic testing, but the policy does not explicitly require a particular prior test (e.g., CMA) in all non-prenatal cases.",Yes,Patient has a family history of dysmorphic features in a sibling. The guideline requires an appropriate genetic and family history evaluation and documentation; the presence of a sibling with dysmorphic features is relevant to eligibility per the policy's emphasis on family history.,Not Specified,"ACMG recommendations for pretest genetic counseling are cited in the guideline, but the Cigna ES coverage criteria do not explicitly require genetic counseling as a mandatory coverage criterion. The patient declined genetic counseling, and the policy does not state denial is automatic for declined counseling.",81415,The policy specifies CPT 81415 should be billed for the proband when analyzing the entire exome sequence.,No,"Although age and clinical features potentially meet the policy's clinical criteria and no prior ES/GS was performed, the Cigna guideline requires that the member 'has had appropriate genetic and family history evaluation, and a clinical letter detailing the evaluation' including differential diagnoses, testing algorithm, previous tests/results, recommendation that ES is most appropriate, and predicted impact on plan of care. The provided patient information does not include this required clinical documentation (and the family declined genetic counseling). Therefore, based strictly on the policy text and available patient information, the required documentation/conditions for coverage are not met.",10475,2650,13125
Case7014,rag,all_correct,iter1,WGS,Patient info explicitly states whole genome sequencing (WGS) is being requested.,Not Specified,The policy does not impose an age exclusion for WGS; age-specific limits are not specified as an eligibility barrier for this indication.,Yes,"Policy requires WGS to be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the test was requested by neurology (neurologist), meeting this requirement.",Yes,"Policy lists 'multiple congenital anomalies (must affect different organ systems)' and nonspecific presentation as an indication for WGS; the infant has multiple congenital anomalies that do not fit a well-delineated syndrome, meeting the clinical indication.",Yes,"Policy requires that neither CMA nor WES have been performed prior to WGS; patient had a nondiagnostic karyotype only and has not had CMA or WES, satisfying this prior-test criterion.",Yes,"Policy identifies 'other first- or second-degree family member(s) with similar clinical features' as a supportive feature; patient has a maternal aunt with a congenital anomaly (second-degree relative), which is relevant.",Yes,"Policy states genetic counseling is strongly recommended prior to WES/WGS; patient completed pre-test genetic counseling with a genetic specialist, meeting the counseling expectation.",81425,"Policy's applicable codes list CPT 81425 as 'Genome (e.g., unexplained constitutional or heritable disorder or syndrome); sequence analysis,' corresponding to WGS.",Yes,"Under the policy WGS is medically necessary when presentation is nonspecific, a specific syndrome/test is not indicated, ordered by an allowed specialist, neither CMA nor WES have been performed, and features such as multiple congenital anomalies are present — all of which are met by this patient.",36945,2258,39203
Case13517,rag,all_correct,iter1,WES,Patient record explicitly states whole exome sequencing (WES) was ordered.,Not Specified,"Policy does not impose a strict age cutoff for WES; some listed clinical features reference diagnoses by age 18 but no general age exclusion applies to a 16-year-old, so age-based eligibility is not specified as disqualifying.",Yes,"Policy requires WES to be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the ordering provider is a developmental pediatrician, which meets the requirement (Coverage Rationale).",Yes,"Coverage criteria allow WES when clinical history strongly suggests a genetic cause and two or more features (e.g., laboratory abnormalities suggestive of an IEM and other first- or second-degree family members with similar clinical features). The patient has conjugated hyperbilirubinemia (laboratory abnormality suggestive of IEM) and a sibling with lab abnormalities suggestive of an IEM, meeting those criteria (Coverage Rationale).",Not Specified,"The policy does not mandate specific prior tests before WES in this outpatient, non-prenatal scenario (it only specifies prior testing for certain prenatal situations or when a specific syndrome is suspected).",Yes,"Policy lists 'other first- or second-degree family member(s) with similar clinical features' as an applicable criterion; the patient has a sibling with laboratory abnormalities suggestive of an IEM, meeting the family-history criterion (Coverage Rationale).",Yes,"Policy states genetic counseling is strongly recommended prior to WES/WGS; the patient completed pre-test counseling with a genetic counselor and has post-test counseling planned, satisfying the counseling recommendation (Description of Services).",81415,"CPT 81415 corresponds to exome (sequence analysis) for an unexplained constitutional or heritable disorder, which matches the ordered WES (Applicable Codes).",Yes,"All applicable policy criteria are met: WES ordered by an approved specialty (developmental pediatrician), clinical history suggests a genetic cause with relevant features (laboratory abnormality suggestive of IEM plus affected sibling), and pre-test genetic counseling completed. Therefore WES is considered medically necessary/covered per the policy's Coverage Rationale.",36953,2866,39819
Case14127,rag,all_correct,iter1,WES,Patient information explicitly states whole exome sequencing (WES) is being pursued.,Yes,"Policy lists Global Developmental Delay and intellectual disability diagnosed by age 18 as qualifying features for WES; the patient is 17 with lifelong GDD, meeting the age-related criteria.",Yes,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the medical geneticist is coordinating/ordering testing.",Yes,"Coverage criteria require nonspecific presentation plus one qualifying feature such as Global Developmental Delay or epileptic encephalopathy onset <3 years. The patient has GDD and a sibling with early-onset epileptic encephalopathy, meeting medical indication criteria.",Not Specified,The WES coverage criteria do not mandate prior specific tests for postnatal WES in this scenario; patient had nondiagnostic FISH but policy does not require specific prior testing before WES.,Yes,Policy lists other first- or second-degree family members with similar clinical features and consanguinity as qualifying factors; the patient has a sibling with epileptic encephalopathy (relevant family history).,Not Specified,Policy 'strongly recommends' genetic counseling prior to WES but does not state counseling as a strict coverage requirement; patient has had pre-test counseling and will return for post-test counseling.,81415,Policy's applicable CPT codes list 81415 for exome (sequence analysis) corresponding to WES (proband) testing.,Yes,"Per the policy, WES is medically necessary when ordered by an authorized specialist for nonspecific presentations and qualifying features (e.g., Global Developmental Delay); the 17-year-old patient with lifelong GDD, family history of early-onset epileptic encephalopathy, medical geneticist order, and pre-test counseling meets the coverage criteria.",36965,1574,38539
Case15820,rag,all_correct,iter1,CMA,Patient information explicitly states chromosomal microarray (CMA) has been ordered; policy is the CMA guideline (MOL.TS.150.A).,Not Specified,"The CMA policy does not impose age-based eligibility limits for postnatal testing; it addresses indications (DD/ID) rather than specific age cutoffs, so age criteria are not specified.",Not Specified,"The policy requires pre- and post-test genetic counseling and that the rendering laboratory be qualified, but it does not specify required ordering provider specialty or type for ordering CMA.",Yes,"Under 'Diagnostic Testing for Symptomatic Individuals' the policy lists developmental delay/intellectual disability (DD/ID) as an approved indication. The patient is a living 31‑year‑old with DD/ID and no prior CMA, meeting the listed clinical criteria.",Yes,"Policy requires 'No previous CMA testing' and that testing be performed on a living child or adult. Patient has no prior genetic testing reported and no prior CMA, so required prior-test conditions are satisfied.",No,The policy specifies family history of chromosome rearrangement in phenotypically normal individuals as an exclusion; the patient’s family history (mother with early breast cancer) is not one of the family/consanguinity criteria that affect CMA eligibility per the policy.,Yes,"Policy requires pre- and post-test genetic counseling. Patient completed multiple pre-test sessions with a genetic counselor and plans post-test follow-up, satisfying the counseling requirement.",81228,The policy lists CPT 81228 (constitutional chromosomal microarray) as a CMA procedure code; the order is for CMA and 81228 is the applicable CMA code referenced.,Yes,"Adjudication: patient meets policy criteria for postnatal diagnostic CMA (living adult with DD/ID, no prior CMA, counseling completed). CMA is reimbursable once per lifetime and no exclusions apply, so the test is covered per the policy.",10097,1463,11560
Case13675,rag,all_correct,iter1,WGS,Patient information states 'whole genome sequencing (WGS) is being pursued' — WGS is the explicitly requested test.,Yes,"Policy criteria for pediatric indications reference features 'diagnosed by 18 years of age.' Patient is an 8‑week‑old infant, which meets the age context for pediatric WGS criteria.",Yes,"UnitedHealthcare policy requires WGS be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The ordering/referring provider is a neonatologist, meeting the policy requirement.",No,"Policy requires either (A) one or more primary features (e.g., multiple congenital anomalies, severe ID, global DD, early epileptic encephalopathy) or (B) two or more listed features (e.g., congenital anomaly, significant hearing/visual impairment, etc.). The infant has significant congenital hearing/visual impairment (one feature) but no second listed feature or any primary feature documented, so medical‑necessity criteria are not met.",Yes,"WGS coverage criteria state it is proven/medically necessary when 'Neither CMA nor WES have been performed.' Patient’s prior testing was nondiagnostic FISH; there is no documentation of prior CMA or WES, satisfying the criterion that neither CMA nor WES have been performed.",No,"Policy lists consanguinity or 'other first- or second-degree family member(s) with similar clinical features' as relevant. The family history documents a father with long QT syndrome, which is not a similar clinical feature to the infant's hearing/visual impairment and no consanguinity is reported, so the policy’s family-history criteria are not met.",Not Specified,"The policy 'strongly recommends' pre‑test genetic counseling prior to WES/WGS but does not list pre‑test counseling as a mandatory coverage criterion. The record notes no documented pre‑test counseling, but counseling is not a specified required coverage criterion in the policy.",81425,"UnitedHealthcare's applicable codes list maps 'Genome (e.g., unexplained constitutional or heritable disorder or syndrome); sequence analysis' to CPT code 81425, which corresponds to WGS.",No,"Although age and ordering provider requirements are met and neither CMA nor WES were performed (per policy), the policy requires either one of the primary features or two or more of the secondary features. The infant has only one listed secondary feature (significant hearing/visual impairment) and no other required clinical features, so the WGS request does not meet the policy's medical‑necessity coverage criteria.",36956,2808,39764
Case2162,rag,all_correct,iter1,WGS,The patient information states whole genome sequencing (WGS) was requested for an infant with multiple congenital anomalies.,Not Specified,"The policy references use in 'children' and includes guidance (ACMG) recommending ES/GS prior to 1 year in supplemental text, but the policy statement itself does not define a strict numeric age cutoff; therefore age-based eligibility is not explicitly specified.",No,Policy criterion 1 requires documentation that the individual has been evaluated by a clinician with expertise in clinical genetics. The ordering/referring provider is a general practitioner and there is no documentation that a clinician with genetics expertise evaluated the infant.,Yes,"Policy lists evaluation of unexplained congenital anomalies in children as a specific medical indication for WES/WGS; the patient is a 7‑week infant with multiple congenital anomalies identified at birth, which meets that medical indication.",No,The policy requires prior standard workup (examples include chromosomal microarray analysis and/or targeted single‑gene testing) or prior testing having failed; only nondiagnostic Fragile X testing is documented and there is no documentation of CMA or other standard prior testing.,Yes,"The policy lists family history of developmental delay/related conditions as relevant; the patient has an older sibling with autism spectrum disorder, which is a relevant family history per the policy.",Yes,"The policy requires counseling about risks of genetic testing performed by someone experienced; the patient information states pre‑test genetic counseling was completed with plans for post‑test follow‑up, satisfying the counseling requirement as documented.",Not Specified,The provided policy text does not specify CPT or billing codes for WGS; no CPT mapping is given in the document.,No,"Although the infant has a policy‑defined medical indication (multiple congenital anomalies), the policy requires (1) evaluation/documentation by a clinician with expertise in clinical genetics and (2) standard prior workup (eg, CMA) or prior testing fail criteria. The record lacks documentation of a genetics clinician evaluation and lacks evidence of required prior testing (CMA/targeted testing), so the policy's ALL‑criteria for medical necessity are not met.",14818,2651,17469
Case7376,rag,all_correct,iter1,WES,Patient information explicitly states whole exome sequencing (WES) has been ordered.,Not Specified,"The policy does not impose an overall age cutoff for WES; it references age for certain diagnostic features (e.g., ID diagnosed by 18) but does not state an age-based eligibility limit that would exclude a 73-year-old.",Yes,"Policy coverage criteria require WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the patient’s WES was ordered by a neurologist, meeting the ordering-provider requirement.",No,"Policy requires that clinical history strongly suggests a genetic cause plus specified features (e.g., congenital anomalies, early-onset ID/DD, multiple listed neurologic/developmental features, consanguinity, or a first/second-degree family member with similar clinical features). The patient has an unexplained major abnormality of at least one organ system and a sister with breast cancer, but the record does not document any of the specific features listed by the policy (e.g., congenital anomalies, early-onset developmental issues, similar affected family members), so the policy medical-indication criteria are not met.",Not Specified,"The WES coverage rationale does not mandate specific prior tests for outpatients (it only states targeted testing should precede WES if a specific syndrome is suspected and prenatal WES requires prior CMA/karyotype). The patient had prior nondiagnostic FISH, but the policy does not list required prior tests for this outpatient WES request.",No,"The policy lists family history of other first- or second-degree members with similar clinical features as a relevant criterion. The patient’s sister has triple-negative breast cancer (a cancer history), which is not documented as a similar phenotype to the patient’s unexplained abnormality and cancer evaluation is addressed separately in oncology policies, so the policy-relevant family-history criterion is not met.",Not Specified,"The policy 'strongly recommends' genetic counseling prior to WES/WGS but does not make counseling an explicit coverage requirement; the patient did receive pre-test counseling, but the policy does not define a mandatory counseling criterion to be met.",81415,Policy 'Applicable Codes' maps WES (exome sequence analysis) to CPT code 81415 (exome; sequence analysis) for a proband exome test.,No,"Under the UnitedHealthcare WES policy, WES is medically necessary only when the clinical presentation is nonspecific and specific additional criteria are met (including a genetic-suggestive history plus one or more listed features or two or more listed features). Although the test is ordered by an approved specialty and counseling was done, the patient’s record lacks the required policy-specified clinical features (e.g., congenital anomalies, early-onset developmental issues, dysmorphic features, consanguinity, or similarly affected first/second-degree relatives). Therefore, per the policy coverage rationale, WES is not covered for this patient.",36945,2760,39705
Case11124,rag,all_correct,iter1,WES,Patient information explicitly states whole-exome sequencing (WES) has been ordered. Basis: patient clinical info.,Yes,"Policy lists global developmental delay and pediatric-onset criteria (e.g., onset prior to 5 years / features diagnosed by 18 years) as indications for WES; the patient is an infant with developmental delay, meeting the age-related criteria. Basis: UnitedHealthcare WES coverage rationale (global developmental delay / pediatric onset).",Not Specified,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The patient info notes referral by an oncologist and that WES was ordered, but does not state the specialty of the ordering provider. Basis: UnitedHealthcare ordering-provider requirement not documented in patient info.",Yes,"Policy medical indications include global developmental delay and other neurodevelopmental features; the infant presents with developmental delay and a family history suggestive of a genetic etiology, meeting a listed clinical indication. Basis: UnitedHealthcare WES coverage rationale (global developmental delay / features suggestive of genetic cause).",Not Specified,"The policy does not mandate prior testing (e.g., CMA) for postnatal WES in neurodevelopmental indications; prior FISH was nondiagnostic but no specific prior-test requirement for WES is defined. Basis: UnitedHealthcare coverage rationale and testing pathway statements.",Yes,"Policy lists other first- or second-degree family members with similar clinical features as a relevant criterion; the patient has an affected sibling with childhood hearing impairment, meeting the family-history criterion. Basis: UnitedHealthcare WES coverage criteria (family member with similar features).",Not Specified,Policy states genetic counseling is 'strongly recommended' prior to WES but does not make counseling a stated mandatory coverage requirement; patient info indicates pre-test counseling was completed. Basis: UnitedHealthcare statement that counseling is strongly recommended (not an explicit coverage prerequisite).,81415,CPT 81415 is the listed code for exome (sequence analysis) in the policy's applicable codes for WES. Basis: UnitedHealthcare applicable CPT codes list (81415 = Exome sequence analysis).,No,"Although the patient meets age and clinical indication criteria (infant with developmental delay and relevant family history), the policy requires WES to be ordered by specific provider types (medical geneticist, neonatologist, neurologist, or developmental pediatrician). The ordering provider specialty is not documented in the patient information (referral by an oncologist only), so the ordering-provider requirement is not satisfied/documented per policy; therefore coverage cannot be confirmed. Basis: UnitedHealthcare WES coverage rationale (ordering-provider requirement) and absence of that documentation in patient info.",36940,2712,39652
Case8051,rag,all_correct,iter1,WES,Patient information states 'whole exome sequencing (WES) ordered.',Yes,"Policy applies to 'children' and infants with congenital anomalies; the patient is a 5‑week infant, which meets the age scope for WES per the policy.",No,"Policy criterion #1 requires evaluation by 'a clinician with expertise in clinical genetics' (and counseling). The order was placed by a family medicine physician and there is no documentation that the infant was evaluated by a clinician with expertise in clinical genetics, so ordering/provider requirement is not met per the policy.",Yes,"Policy states WES may be medically necessary for evaluation of unexplained congenital anomalies in children when criteria met. The patient has a major congenital cardiac anomaly unexplained by prior testing, consistent with a policy-defined indication.",Yes,"Policy requires that previous genetic testing has failed to yield a diagnosis (examples: CMA and/or targeted testing) OR genetic etiology considered likely despite prior testing. The patient had prior FISH testing that was nondiagnostic, meeting the 'previous genetic testing failed to yield a diagnosis' condition in the policy.",No,"The policy lists specific family history items relevant to selection (eg, arrhythmia, developmental delay, LQTS, sudden unexplained death). The only family history documented is a mother with short stature, which is not one of the policy's specified family-history criteria for eligibility.",Yes,"Policy criterion #1 requires counseling about risks of genetic testing. Patient/family completed pre‑test genetic counseling and will follow up after results, meeting the policy's counseling requirement.",81415,The requested test is whole exome sequencing (WES); CPT 81415 corresponds to exome sequencing.,No,"Although the infant meets age, clinical indication (unexplained major congenital anomaly), prior nondiagnostic genetic testing, and has pre‑test counseling, the policy requires documentation that the individual has been evaluated by a clinician with expertise in clinical genetics. That documentation is not present (order placed by family medicine physician), so not all required policy criteria are met and coverage is not supported per the policy.",14840,2711,17551
Case19905,rag,all_correct,iter1,WES,Patient is being considered for whole exome sequencing (WES) per the clinical information.,Yes,"Policy age-related criteria (e.g., features diagnosed by age 18) are met for a 3-year-old; no policy exclusion for this age and pediatric criteria apply (policy: WES indications include pediatric-onset features diagnosed by 18 years).",Yes,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the ordering/referring provider is a developmental pediatrician (meets policy).",Yes,Policy lists 'multiple congenital anomalies (must affect different organ systems)' as an explicit indication for WES; patient has multiple congenital anomalies per clinical info.,Not Specified,"Policy does not mandate specific prior tests for postnatal WES in this scenario (prenatal WES requires CMA/karyotype, but postnatal criteria do not specify required prior testing); patient had a nondiagnostic karyotype but prior-test requirements are not defined as mandatory.",No,"Policy-relevant family history criteria include consanguinity or first/second-degree relatives with similar clinical features; the provided family history (mother with long QT syndrome) is not described as similar to the child's multisystem congenital anomalies, so it is not a relevant family-history criterion per policy.",Not Specified,"Policy states genetic counseling is 'strongly recommended' prior to WES but does not make counseling a formal coverage requirement; the patient has not had counseling, and the policy does not require it as a condition of coverage.",81415,Policy's applicable CPT codes list 81415 for exome sequence analysis (WES) for unexplained constitutional or heritable disorder or syndrome.,Yes,"Per the UnitedHealthcare WES coverage rationale, WES is medically necessary when ordered by a developmental pediatrician for a nonspecific presentation and one qualifying feature is present; patient is a 3-year-old with nonspecific multiple congenital anomalies and WES is ordered by a developmental pediatrician, so coverage criteria are met.",36917,2065,38982
Case10850,rag,all_correct,iter1,WGS,Patient information explicitly states whole genome sequencing (WGS) has been ordered.,Yes,"Policy does not impose an upper age exclusion for WGS and the patient is a 13‑year‑old child; policy criteria include neurodevelopmental features (e.g., Global Developmental Delay) diagnosed by age 18, which the patient meets.",Yes,"Policy requires WGS be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the ordering provider is a developmental pediatrician.",Yes,"Policy medical‑necessity criteria list Global Developmental Delay and/or dysmorphic features/family members with similar features as indications; the patient has global developmental delay and a family history (aunt with dysmorphic features), meeting the clinical indication.",Yes,"Policy requires that neither CMA nor WES have been performed prior to WGS; the record documents only prior nondiagnostic FISH and does not report prior CMA or WES, so the patient meets this prior‑test requirement.",Yes,Policy lists other first‑ or second‑degree family members with similar clinical features as a criterion; the patient has an aunt with dysmorphic features (a relevant second‑degree relative).,Not Specified,Policy states genetic counseling is 'strongly recommended' prior to WES/WGS but does not make counseling a formal coverage requirement; patient did complete pre‑test counseling.,81425,"Policy 'Applicable Codes' lists 81425 for genome (e.g., unexplained constitutional or heritable disorder or syndrome) sequence analysis corresponding to WGS.",Yes,"All applicable policy criteria for WGS are met: ordered by a developmental pediatrician, patient has Global Developmental Delay and relevant family history, no prior CMA or WES documented, and testing is being pursued to evaluate a genetic etiology that would influence management per policy.",36937,3049,39986
Case19321,rag,all_correct,iter1,WES,Patient clinical information explicitly states whole exome sequencing (WES) is being pursued.,Yes,"Policy age-references (e.g., diagnostic criteria referencing onset/diagnosis by 18 years) are specified for pediatric indications; the patient is 1 year old and thus within the pediatric age references in the policy.",Yes,"Policy requires WES to be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the patient was referred by a neurologist, meeting the ordering-provider requirement.",No,"UnitedHealthcare policy requires either (A) the proband to have one of: multiple congenital anomalies, moderate/severe intellectual disability by age 18, global developmental delay, or early epileptic encephalopathy; or (B) two or more listed features (which include autism plus additional features such as congenital anomaly, family members with similar features, consanguinity, etc.). The record documents features concerning for ASD but does not document a second qualifying feature in the proband (e.g., confirmed global developmental delay, congenital anomaly, hypotonia, epilepsy) or clearly similar affected first/second-degree relatives, so the specific medical-indication criteria in the policy are not met.",Not Specified,"The policy does not mandate prior CMA before WES for postnatal cases (CMA is a prerequisite only in specified prenatal pathways); patient did have prior nondiagnostic CMA, but the policy does not explicitly require prior testing for WES in this outpatient pediatric context.",Yes,"The policy lists family history/affected first- or second-degree relatives as a relevant criterion; the patient has a maternal aunt (a second-degree relative) with multiple congenital anomalies, so a relevant family history is present per the policy's family-history considerations.",Not Specified,"Policy states genetic counseling is 'strongly recommended' prior to WES/WGS but does not make counseling an explicit coverage prerequisite; patient did complete pre-test genetic counseling, but the policy frames counseling as recommendation rather than a required coverage criterion.",81415,"Policy's applicable CPT codes list 81415 for exome (sequence analysis), which corresponds to WES as requested.",No,"Although ordering-provider and age criteria are met and prior CMA was nondiagnostic, UnitedHealthcare coverage requires the proband to meet specific clinical-feature criteria (one of the listed major features or two or more of the secondary features). The patient has suspected ASD but lacks documentation of a second qualifying proband feature (e.g., global developmental delay, congenital anomalies, hypotonia, epilepsy) or clearly similar affected first/second-degree relatives; therefore the policy's defined medical necessity criteria are not satisfied.",36944,3591,40535
Case2496,rag,all_correct,iter1,WES,Patient clinical information explicitly states whole exome sequencing (WES) is being requested for a prenatal evaluation.,Not Specified,The policy does not impose an age limit for prenatal WES; gestational age (32 weeks) is provided but the policy’s prenatal WES coverage criteria are not age-based.,No,"Policy prenatal WES requires the test be ordered by or in consultation with a medical geneticist or maternal-fetal medicine specialist; the ordering provider in the record is a neonatologist with no documented consultation, so provider requirement is not met (Policy: ""WES is ordered by or in consultation with a medical geneticist or maternal-fetal medicine specialist"").",No,"Prenatal WES coverage requires the fetus to have one or more specific findings (multiple congenital anomalies, fetal hydrops of unknown etiology, or a single-system congenital anomaly with supportive family history) and other criteria; the record does not document these required fetal findings or other required prenatal criteria, so the patient does not meet the specified prenatal indications.",No,"Policy requires chromosome microarray analysis (CMA) and/or karyotyping to have been performed and uninformative prior to prenatal WES; the patient had prior FISH testing only (nondiagnostic) and no CMA/karyotype is documented, so the required prior testing was not completed.",Yes,"The patient has parental consanguinity and a family history (sibling with sudden unexplained death); the policy lists consanguinity as a relevant criterion for WES/WGS (Policy lists ""Consanguinity"" among features that support WES/WGS).",Not Specified,"The policy states genetic counseling is ""strongly recommended"" prior to WES/WGS but does not make counseling an absolute required coverage criterion for prenatal WES, and the record documents no counseling—the policy guidance is recommendation rather than a strict coverage requirement.",81415,"Policy applicable codes list 81415 for exome (sequence analysis); WES corresponds to CPT code 81415 (Policy Applicable Codes: ""81415 Exome ... sequence analysis"").",No,"Under the policy prenatal WES is covered only when all prenatal-specific criteria are met (CMA/karyotype uninformative; ordered by or in consultation with a medical geneticist or MFM; appropriate fetal findings and sample source). The patient record lacks documented CMA/karyotype, shows the order from a neonatologist without documented genetics/MFM consultation, and does not document the required fetal anomaly criteria, therefore coverage criteria are not met.",36957,3126,40083
Case6867,rag,all_correct,iter1,BRCA1/2,Patient specifically presents for BRCA1 and BRCA2 testing per clinical information.,Yes,"Policy includes testing for individuals with a personal history of breast cancer diagnosed at any age when there is ≥1 close blood relative with metastatic or intraductal/cribriform prostate cancer; patient is 50 with a brother with metastatic/intraductal prostate cancer, satisfying age-related criteria in the policy.",Not Specified,"Policy requires testing be performed in a setting with suitably trained providers and access to a CLIA lab and recommends genetic counseling, but it does not specify a required ordering provider specialty or restrict ordering to specific provider types.",Yes,Policy states genetic testing is medically necessary for individuals with a personal history of breast cancer who have ≥1 close blood relative with metastatic or intraductal prostate cancer; the patient has a personal history of breast cancer and a brother with metastatic intraductal prostate cancer.,Not Specified,"Policy recommends testing an affected family member first when testing unaffected relatives, and notes options for prior limited testing, but does not mandate specific prior tests that must be completed before BRCA1/2 germline testing in this scenario.",Yes,"Policy explicitly uses family history as qualifying criteria; the patient has a brother with metastatic intraductal prostate cancer and a mother with breast cancer, which are relevant family-history criteria.",Yes,"Policy requires testing be performed in a setting with appropriate pre- and post-test counseling and recommends formal genetic counseling; patient had multiple pre-test counseling visits with a genetic counselor, meeting the counseling requirement.",Not Specified,The provided policy document does not specify CPT or billing codes for BRCA1/2 testing; no CPT mapping is given in the policy text supplied.,Yes,"Per the policy, BRCA1/2 testing is medically necessary for an individual with a personal history of breast cancer who has a close blood relative with metastatic/intraductal prostate cancer; patient meets these criteria and has received genetic counseling, so the test is covered.",18950,2185,21135
Case1130,rag,all_correct,iter1,WES,Patient information explicitly states the patient is undergoing whole exome sequencing (WES). Basis: patient clinical note.,Not Specified,"Policy does not impose a single age cutoff for WES; coverage criteria are phenotype- and onset-based (e.g., epileptic encephalopathy with onset <3 years, ID diagnosed by 18 years). Patient is 68 but policy does not state a blanket exclusion by age, so age-based eligibility is not explicitly specified for this adult patient.",Not Answerable,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The patient information does not state the specialty of the ordering provider, so it cannot be determined if ordering-provider requirements are met.",No,"Policy coverage requires specific clinical indications (e.g., epileptic encephalopathy with onset before 3 years, or ≥2 listed features such as congenital anomalies, global developmental delay, consanguinity, or other family members with similar features). The record notes persistent seizures but does not document early-onset epileptic encephalopathy, developmental delay, consanguinity, or other qualifying features, so the patient does not meet the policy-defined medical indications.",Not Specified,"Policy does not require a specific prior test for outpatient WES (except that targeted/single-gene testing should be done if a specific syndrome is suspected). The patient had prior nondiagnostic FISH, but the policy does not list FISH or other prior testing as a required step for WES in this scenario.",No,"Policy lists family history of other first- or second-degree relatives with similar clinical features (or consanguinity) as a criterion. Patient reports a sister with ovarian/fallopian/peritoneal carcinoma, which is not a similar neurologic phenotype, and consanguinity is not reported; thus the patient does not meet the policy's family-history criteria.",Yes,"Policy 'strongly recommends' genetic counseling prior to WES/WGS. Patient has seen a genetic counselor multiple times with plans for post-test follow-up, meeting the counseling recommendations described in the policy.",81415,Policy lists CPT 81415 for exome (sequence analysis) which corresponds to whole exome sequencing (WES).,No,"Based on the UnitedHealthcare WES policy, coverage requires meeting specified clinical criteria (e.g., early-onset epileptic encephalopathy or multiple qualifying features). The patient is an adult with persistent seizures but lacks documentation of the policy-defined qualifying features (and ordering-provider specialty is not documented). Although counseling is documented, the patient does not meet the policy's medical-necessity criteria for WES; therefore the test is not covered per the policy.",36951,2900,39851
Case5303,rag,all_correct,iter1,BRCA1/2,"Patient was referred specifically for BRCA1 and BRCA2 testing per the clinical information; policy lists BRCA1/2 testing as a distinct category (Coverage Rationale, BRCA1/2).",Not Specified,"Policy age-based criteria apply specifically to individuals with a personal history of breast cancer (e.g., diagnosed ≤65). The patient is 37 but does not have a personal history of breast cancer, so no age-based eligibility criterion in the policy directly applies to this unaffected individual requesting BRCA testing.",Not Specified,"The policy strongly recommends pre-test genetic counseling and involvement of providers with genetics expertise, but it does not impose a specific required ordering provider specialty for BRCA1/2 testing as a coverage criterion.",No,"Policy defines medical indications for BRCA1/2 testing (e.g., personal history of breast cancer ≤65 or specific family history criteria for unaffected individuals). The patient has no personal history of a primary solid tumor and the family history (brother died suddenly <35, not described as cancer) does not meet the policy's family-history criteria, so the patient does not meet a defined medical indication.",Not Specified,"The policy recommends pre-test genetic counseling but does not mandate prior testing (e.g., tumor testing or other specific prior tests) as a prerequisite for BRCA1/2 germline testing in this scenario; no required prior tests are specified for an unaffected individual in the provided text.",No,"Family-history criteria for BRCA testing are specified in the policy (first-/second-degree relatives with BRCA-related cancers, etc.). The patient's only noted family history is a brother who died suddenly <35 with no cancer history documented, which does not satisfy the policy's family-history requirements.",Not Specified,"The policy 'strongly recommends' pre-test genetic counseling but does not make counseling a strict coverage requirement. The patient did not receive pre-test counseling, but counseling is not specified as a mandatory coverage criterion in the policy.",81162,"Policy lists CPT 81162 for BRCA1/BRCA2 full sequence analysis and full duplication/deletion analysis, which corresponds to a full BRCA1/2 test as requested.",No,"Per the UnitedHealthcare policy coverage rationale, BRCA1/2 testing is proven/medically necessary for individuals meeting defined personal- or family-history criteria. This patient is an unaffected individual without the policy-specified family-history features and therefore does not meet the coverage criteria for BRCA1/2 testing.",38601,1646,40247
Case7447,rag,all_correct,iter1,WGS,Patient info states the cardiologist has ordered whole genome sequencing (WGS) for the fetus.,No,Policy defines age-based indications for postnatal children and critically ill neonates/infants and explicitly excludes prenatal (fetal) testing; the patient is a fetus and therefore does not meet the policy's age/site criteria.,No,Policy requires evaluation by a clinician with expertise in clinical genetics (documentation of genetics evaluation) before WES/WGS; the order was from a cardiologist and there is no documentation that a clinical genetics evaluation was done.,No,Policy specifies medical indications for WES/WGS in postnatal children or critically ill infants and explicitly states it does not address prenatal (fetal) testing; an isolated fetal congenital heart defect at 33 weeks is a prenatal indication not covered by the policy.,No,"Policy for diagnostic WES/WGS requires prior appropriate genetic workup (eg, chromosomal microarray and/or targeted testing) where applicable; only nondiagnostic fragile X testing is documented and there is no documentation of required prior testing such as CMA.",No,"Policy lists specific family-history criteria (eg, arrhythmia, developmental delay, LQTS, sudden unexplained death) relevant to testing; the documented family history (maternal aunt with triple-negative breast cancer) is not among the policy-specified family-history criteria.",No,Policy requires counseling by an individual experienced in genetic medicine and documentation that the individual was counseled; there is no documentation of pre-test genetic counseling for this patient.,Not Specified,"The provided BCBS_FEP policy document does not list or map specific CPT codes to WGS/WES, so a CPT code cannot be selected from the policy text.",No,"Per the BCBS_FEP policy, WGS/WES coverage applies to postnatal children or critically ill infants under specified criteria and the policy explicitly does not address prenatal (fetal) testing; the requested prenatal WGS and the submitted documentation do not meet the policy's coverage requirements.",14825,2059,16884
Case16126,rag,all_correct,iter1,BRCA1/2,Patient information states BRCA1 and BRCA2 testing has been ordered. Basis: patient clinical info.,No,"Policy explicitly states ""Genetic testing in minors for BRCA1, BRCA2, and PALB2 ... is considered investigational."" The patient is a 6-week-old infant, so age-based criteria are not met.",Not Specified,Policy requires testing be performed in a setting with suitably trained providers who provide pre/post-test counseling but does not specify required ordering provider specialty. Patient's ordering provider is a gynecologist but policy does not mandate a specific specialty.,No,"Policy defines medical indications (personal history of relevant cancers or family history meeting criteria). The infant has congenital anomalies, no personal or qualifying family history of BRCA-related cancers documented, so does not meet the policy's medical indications.",No,"Policy strongly recommends testing an affected family member first when testing an unaffected individual. The patient (unaffected infant) has no documentation of an affected family member having been tested, so recommended prior testing was not completed.",No,"Policy's family-history criteria relate to cancers in 1st–3rd degree relatives or known familial BRCA/PALB2 variants. Although parents are reported consanguineous, no qualifying family cancer history or known familial BRCA/PALB2 variant is documented, so family-history criteria are not met.",Yes,"Policy requires appropriate pre- and post-test genetic counseling by experienced providers. Patient info states pre-test counseling was completed and post-test follow-up with a genetic counselor is planned, meeting counseling requirements.",Not Specified,"The provided policy document does not specify CPT codes for BRCA1/BRCA2 testing. No CPT mapping appears in the policy text, so a specific CPT from the list cannot be determined from the policy.",No,"Per policy, genetic testing for BRCA1/BRCA2 in minors is considered investigational. The patient is a 6-week-old infant; despite counseling being performed, the age-based policy contraindicates coverage, so the test is not covered.",18931,2260,21191
Case4512,rag,all_correct,iter1,WGS,Patient information explicitly states whole genome sequencing (WGS) is being pursued.,No,"Policy limits medically necessary standard WES/WGS indications to children (and rapid WGS/WES to critically ill infants in NICU/PICU). The patient is a 21-year-old adult, so age does not meet the pediatric/infant criteria in the policy (policy basis: ""Standard whole exome sequencing... may be considered medically necessary ... in children"" and ""rapid WGS... for critically ill infants"").",Not Answerable,Policy requires evaluation by a clinician with expertise in clinical genetics (including family history/phenotype) and counseling. Patient record documents pre-test genetic counseling but does not explicitly state evaluation by a clinician with expertise in clinical genetics; insufficient information to determine provider requirement compliance (policy basis: criterion #1).,No,"Policy defines medical indications for WGS only for rapid testing in critically ill infants; otherwise WGS is considered investigational. The 21-year-old adult with a congenital cardiac anomaly does not meet the policy's defined indications for WGS (policy basis: ""Rapid ... WGS ... may be considered medically necessary ... for critically ill infants"" and ""Whole genome sequencing is considered investigational for the diagnosis of genetic disorders in all other situations"").",Not Specified,"The policy specifies prior genetic testing (eg, CMA and/or targeted single-gene testing) as part of the WES criteria for children, but does not define a required prior-test pathway for standard WGS in non-rapid situations. The patient has no prior genetic testing, but the policy does not state specific prior-test requirements for this requested WGS scenario.",Yes,"Policy explicitly lists family history items relevant to testing eligibility, including 'BRUE in sibling.' The patient has a sibling with a BRUE-like event (policy basis: Policy Guidelines family history list).",Yes,"Policy requires genetic counseling by an experienced individual; patient information documents pre-test counseling with a genetic counselor and a planned post-test visit, meeting the counseling requirement (policy basis: 'Genetic counseling... should be performed by an individual with experience and expertise').",81425,The requested test is whole genome sequencing (WGS); the CPT code option corresponding to WGS among the provided choices is 81425.,No,"Under the policy, whole genome sequencing is considered investigational for diagnosis in all situations other than rapid testing for critically ill infants; this patient is a 21-year-old adult and does not meet the policy's covered indications, so WGS is not covered (policy basis: 'Whole genome sequencing is considered investigational for the diagnosis of genetic disorders in all other situations').",14859,2640,17499
Case1778,rag,all_correct,iter1,WES,Patient information explicitly states whole exome sequencing (WES) has been requested.,Yes,"Policy requires member <21 years of age for ES; patient is 14, meeting the age criterion.",Not Answerable,"Policy requires an appropriate genetic/family history evaluation and a clinical letter with specific elements (differential, testing algorithm, prior tests/results, recommendation for ES). The patient record only notes referral by a PCP and does not document the required clinical letter or ordering provider qualifications, so sufficiency cannot be determined from the provided information.",No,"Policy defines specific clinical indications (e.g., multiple congenital anomalies affecting different organ systems, neurodevelopmental criteria, or two listed features). Patient has an isolated ocular coloboma (single organ system) and does not meet the listed ES indications from the policy.",No,"Policy requires prior evaluation documentation and lists prior testing/results as required in the clinical letter; patient has only prior nondiagnostic FISH documented and no evidence of the required genetic evaluation/clinical letter or other prior testing (e.g., CMA) in the record provided.",No,The policy references family history in required documentation and for certain prenatal indications; the provided patient information contains no family history or consanguinity relevant to eligibility.,No,Policy and cited ACMG guidance require pretest counseling (medical geneticist or genetic counselor) and documented consent/clinical letter; the patient information does not document genetic counseling or consent meeting these requirements.,81415,Policy specifies CPT 81415 is the appropriate code to bill for proband whole exome sequencing (analysis of the entire exome).,No,"Although age and requested test type align with policy and CPT 81415 is appropriate, the patient does not meet the policy's defined medical-necessity clinical criteria (isolated single-organ ocular coloboma does not satisfy required indications), and required documentation/genetic evaluation and counseling are not provided; therefore ES is not covered per the policy criteria.",10435,2557,12992
Case14155,rag,all_correct,iter1,WGS,"Patient information explicitly states ""whole genome sequencing (WGS) has been requested.""",Yes,"Policy lists an age requirement of ""Member is <21 years of age"" for genome sequencing; the patient is 7 years old, meeting this criterion.",No,"The guideline requires an ""appropriate genetic and family history evaluation"" and a clinical letter detailing evaluation (differential, testing algorithm, previous tests/results, recommendation that GS is most appropriate). The record shows referral by neurology but does not document the required evaluation/clinical letter or pre-test counseling; therefore provider/order requirements are not satisfied per policy.",No,"Policy requires specific clinical indications (e.g., global developmental delay <5 y, moderate/severe ID, multiple major anomalies, or TWO listed neurodevelopmental criteria including autism plus another). The child has isolated autism spectrum disorder without other listed features or documented ID or additional qualifying criteria; isolated autism alone does not meet the policy's GS clinical criteria.",No,"The guideline requires documentation of prior testing and consideration of standard first‑tier testing (e.g., CMA, targeted panels) and a clinical letter listing ""previous tests performed and results."" The patient has had no prior genetic testing and no documentation of required prior evaluations, so required prior testing/documentation has not been completed.",Not Specified,"The policy references family history as part of the required genetic/family history evaluation and includes family history as an explicit criterion only for rapid WGS inpatient criteria. It does not specify that a maternal uncle with an immunologic disorder alone satisfies standard GS eligibility, so family‑history eligibility is not explicitly specified for this scenario.",No,"ACMG guidance cited in the policy and the GS criteria require pretest genetic counseling/appropriate genetic evaluation; the family declined pre-test genetic counseling, so the counseling requirement is not met per the policy.",81425,The policy lists 81425 as the appropriate CPT for genome sequencing (proband whole genome sequence analysis).,No,"Per the Cigna GS guideline all listed criteria must be met (including documented genetic/family history evaluation with clinical letter, meeting defined clinical indications beyond isolated autism, prior testing/documentation as appropriate, and pretest counseling). Multiple required elements are not met (isolated autism without additional qualifying features, no prior testing/documentation, and no pretest genetic counseling), therefore coverage is not indicated.",9161,2701,11862
Case13406,rag,all_correct,iter1,WGS,Patient information states 'Whole genome sequencing (WGS) has been ordered by a medical geneticist.' Basis: patient record.,Yes,"Policy lists pediatric age-based features (e.g., Global Developmental Delay with onset prior to 5 years; intellectual disability diagnosed by age 18). The patient is an infant (6 weeks), which meets the pediatric age context in the policy.",Yes,"Policy requires WGS be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. Basis: WGS was ordered by a medical geneticist per patient information.",Yes,Policy lists 'Global Developmental Delay' as an explicit clinical criterion for WGS. Basis: patient is being evaluated for concern of global developmental delay.,No,"Policy coverage for WGS requires 'Neither CMA nor WES have been performed.' The patient had chromosome microarray (CMA) previously performed (nondiagnostic), so the policy's prior-test requirement for WGS is not met.",No,Policy counts family history of similar features or consanguinity as relevant criteria. The patient has a sibling with a brief resolved unexplained event (not described as similar to the proband's global developmental delay) and no consanguinity reported; therefore the policy's family/consanguinity criteria are not met.,Not Specified,"Policy 'strongly recommends' genetic counseling prior to WES/WGS but does not state counseling as a strict coverage requirement. Patient had pre-test counseling, but the policy frames counseling as recommendation rather than a coverage criterion.",81425,"Policy Applicable Codes list CPT 81425 for 'Genome (e.g., unexplained constitutional or heritable disorder or syndrome); sequence analysis' which corresponds to WGS.",No,"Although the patient meets clinical indication (global developmental delay) and the ordering provider requirement, the policy's WGS coverage criterion requires that 'Neither CMA nor WES have been performed.' The patient had prior CMA (nondiagnostic); therefore under the policy WGS is not covered.",36966,2379,39345
Case3581,rag,all_correct,iter1,BRCA1/2,"Patient information states ""BRCA1 and BRCA2 testing has been ordered."" Basis: patient clinical info.",Yes,"Policy requires age ≥18 for BRCA analyses (Known familial, Ashkenazi, Full Sequence). Patient is 69, which meets the age requirement. Basis: Cigna BRCA Analysis criteria (Age 18 years or older).",Not Specified,Policy does not specify required ordering provider specialty; it specifies genetic counseling by an appropriate provider and that rendering laboratory be qualified but does not restrict who may order. Basis: Cigna BRCA Analysis (Genetic Counseling and Rendering laboratory requirements).,No,"Policy defines specific clinical/diagnostic indications focused on personal or family history of breast, ovarian, pancreatic, prostate cancers or known familial BRCA mutation. The patient’s history (hearing/visual impairment since age 18) and sibling BRUE do not meet any BRCA indications in the policy. Basis: Cigna BRCA Analysis diagnostic and personal/family history criteria.",Not Specified,"The policy lists prior BRCA genetic testing exclusions (eg, no prior full sequencing for full sequence request) but does not require specific prior non-BRCA tests (FISH is not referenced). There is no specified prior genetic test the patient must have completed in this scenario. Basis: Cigna BRCA Analysis (Previous Genetic Testing sections).",No,Policy specifies family-history criteria (first-/second-/third-degree relatives with relevant cancers). The patient’s family history (sibling with brief resolved unexplained event) is not one of the BRCA family-history criteria. Basis: Cigna BRCA Analysis family history definitions and indication lists.,No,Policy requires pre- and post-test genetic counseling by an appropriate provider for BRCA testing. The patient has had no pre-test genetic counseling. Basis: Cigna BRCA Analysis (Genetic Counseling requirement).,81162,"Policy lists CPT codes and states that when BRCA sequencing and deletion/duplication analysis are performed concurrently, CPT 81162 (full sequencing and duplication/deletion combined) is likely most appropriate. The request is for BRCA1/2 testing; 81162 best corresponds per policy. Basis: Cigna BRCA Analysis procedure codes and billing section.",No,Coverage criteria are unmet: patient does not meet BRCA medical/diagnostic indications (no relevant personal or family cancer history) and has not completed required pre-test genetic counseling; policy requires both indication-based criteria and pre/post-test counseling. Therefore testing is not covered per the Cigna BRCA Analysis guideline. Basis: Cigna BRCA Analysis diagnostic/Personal & Family History criteria and Genetic Counseling requirement.,10276,1870,12146
Case10529,rag,all_correct,iter1,WES,Patient record explicitly states whole exome sequencing (WES) is being pursued.,Yes,"Policy age criteria include 'Intellectual Disability diagnosed by 18 years of age' as an indication for WES; the patient is 6 years old with intellectual disability, meeting the age-based criterion.",Yes,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the child was referred by neurology and WES is being pursued via that evaluation, which satisfies the ordering-provider requirement per policy.",Yes,"Policy indicates WES is medically necessary when presentation is nonspecific and one or more features (e.g., intellectual disability, global developmental delay, or other neurologic abnormality or affected first/second-degree family member) are present; the patient has nonsyndromic developmental delay and intellectual disability and a second-degree relative with neurologic disease, meeting the clinical criteria.",Not Specified,"Policy does not mandate specific prior testing (e.g., CMA) for WES in this outpatient pediatric ID/DD scenario; it only states targeted testing should precede WES if a specific syndrome is suspected. Fragile X was done and nondiagnostic per patient info, and no other prior-test requirement is specified by the policy for this situation.",Yes,"Policy lists 'other first- or second-degree family member(s) with similar clinical features' and consanguinity as relevant criteria; the patient has a maternal uncle (a second-degree relative) with dystonia and ataxia, which is relevant per policy.",Yes,"Policy states genetic counseling is strongly recommended prior to WES; the family has seen a genetic counselor multiple times and pre-test counseling is complete with plans for post-test follow-up, meeting the counseling recommendation in the policy.",81415,Policy's Applicable Codes list maps exome sequence analysis (WES) to CPT code 81415; WES (proband) corresponds to 81415.,Yes,"Per the policy WES is medically necessary when (1) results are expected to influence management and (2) criteria are met: nonspecific presentation (not a well-defined syndrome), ordering by an approved specialist, and presence of qualifying features such as intellectual disability or affected first/second-degree family member. The patient is a 6-year-old with nonsyndromic developmental delay/intellectual disability, has an affected second-degree relative, was referred/managed by neurology, and has completed pre-test counseling—thus meeting the policy coverage criteria for WES.",36949,2927,39876
Case18821,rag,all_correct,iter1,WES,The obstetrician requested fetal whole exome sequencing (WES) at 22 weeks' gestation (patient information explicitly states WES).,Not Specified,"The policy's age-based criteria address children/infants (WES/WGS for children or critically ill neonates) but the policy explicitly states it does not address prenatal (fetal) testing, so age-based eligibility for a fetus is not specified in the policy.",No,"Policy criterion 1 requires evaluation by a clinician with expertise in clinical genetics and counseling about risks; the ordering provider is an obstetrician and the record has no documentation of evaluation by a genetics clinician or pre-test genetic counseling, so ordering-provider requirements are not met per the policy.",Yes,"The policy defines multiple congenital anomalies as a specific clinical indication for WES/WGS in examples; the fetus has multiple congenital anomalies affecting different organ systems, so the clinical indication criterion (multiple congenital anomalies) is met, notwithstanding the policy's exclusion of prenatal testing.",No,"Policy states WES is indicated when a genetic etiology is likely despite previous genetic testing or after prior testing (eg, chromosomal microarray and/or targeted single-gene testing) has been done/failed; the patient has no prior genetic testing documented, so required prior testing criteria are not completed.",Not Specified,"The policy discusses family history examples relevant to sequencing in some contexts (eg, family history of developmental delay, inborn errors), but it does not specify dysmorphic features in a maternal aunt as an explicit qualifying family-history criterion for WES; family-history eligibility for prenatal WES is not specified.",No,"Policy criterion 1 requires that the individual be counseled about potential risks of genetic testing by a clinician with genetics expertise; there is no documentation of pre-test genetic counseling for this patient, so the counseling requirement is not met.",81415,"Of the CPT options provided, 81415 corresponds to whole exome sequencing (WES), which is the test requested.",No,"The policy explicitly states it does not address prenatal (fetal) testing and WES/WGS outside the described pediatric/critically ill infant indications is considered investigational; additionally, required criteria (evaluation by a genetics clinician and pre-test counseling, and prior testing) are not met in this case, so fetal WES is not covered under the policy.",14844,2129,16973
Case5230,rag,all_correct,iter1,WES,Patient was referred for whole exome sequencing (WES) per the clinical information; request is explicitly WES.,Not Specified,"The policy does not impose an overall age cutoff for WES; age-related items (e.g., ID diagnosed by 18 years) are criteria elements but there is no discrete age exclusion that would make a 15‑year‑old ineligible.",Yes,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the test was ordered/referred by neurology, meeting the provider requirement.",Yes,"Policy requires clinical history suggesting a genetic cause plus specific features. The patient has a congenital anomaly and a first‑degree family history of an inborn error of metabolism (sibling), meeting two listed features that support WES per policy.",Not Specified,"The policy does not mandate specific prior tests before WES (aside from targeted testing if a specific syndrome is suspected); although the patient had a nondiagnostic CMA, the policy does not require prior testing as a universal prerequisite.",Yes,"Policy lists 'other first- or second-degree family member(s) with similar clinical features' and consanguinity as relevant criteria. The patient has a sibling with an inborn error of metabolism, which is relevant family history per the policy.",Not Specified,"The policy states genetic counseling is strongly recommended prior to WES/WGS but does not make counseling a strict mandatory coverage requirement; the patient declined counseling, and the policy does not explicitly require it for coverage.",81415,Applicable CPT list in the policy maps exome sequence analysis to CPT code 81415.,Yes,"Per the policy, WES is medically necessary when ordered by an approved provider and the clinical history suggests a genetic cause with qualifying features. The patient (15 yo) was referred by neurology, has a congenital anomaly and relevant family history, and had a nondiagnostic CMA — meeting the policy's coverage rationale for WES.",36915,2308,39223
Case6478,rag,all_correct,iter1,BRCA1/2,Patient is being referred for germline BRCA1 and BRCA2 testing (explicit in the clinical information).,Not Specified,"Policy specifies age criteria for BRCA1/2 testing in the context of breast cancer (≤65), but does not set an age limit for BRCA testing when the indication is metastatic prostate cancer; the patient is 52, but no age-based exclusion/applicability is specified for this indication.",Not Specified,Policy recommends genetic counseling and involvement of providers familiar with hereditary cancer but does not state a specific required ordering provider specialty/type for BRCA1/2 germline testing.,Yes,"Policy lists 'metastatic prostate cancer' as a qualifying personal history for medically necessary hereditary cancer testing (including genes such as BRCA1/2); the patient has metastatic prostate cancer, satisfying a defined clinical criterion.",Not Specified,Policy strongly recommends pre-test genetic counseling but does not mandate completion of specific prior tests before germline BRCA1/2 testing in the setting of metastatic prostate cancer; no required prior testing is specified.,Yes,Policy coverage criteria include individuals with prostate cancer who have at least one first- or second-degree relative with a BRCA-related cancer (pancreatic cancer is listed as BRCA-related); the patient’s father had pancreatic cancer (first-degree).,Not Specified,"Policy states pre-test genetic counseling is 'strongly recommended' but does not make counseling an absolute coverage requirement; the patient did not have pre-test counseling, but the policy does not make that a coverage disqualifier.",81162,Requested test is germline BRCA1/2 full analysis; CPT 81162 corresponds to BRCA1/BRCA2 full sequence analysis plus duplication/deletion analysis as listed in the policy.,Yes,"Under the policy, individuals with a personal history of metastatic prostate cancer meet clinical criteria for medically necessary hereditary cancer testing and BRCA1/2 are included among prostate cancer susceptibility genes; the patient’s metastatic disease and first-degree relative with pancreatic cancer further align with listed criteria.",38617,2069,40686
Case13613,rag,all_correct,iter1,WES,Patient text explicitly states whole exome sequencing (WES) is being requested for prenatal evaluation of fetal anomalies.,Not Specified,Policy's prenatal WES criteria do not include an age limit for the fetus; no age-based eligibility criterion applicable to this prenatal WES request is specified in the policy.,Yes,"Policy requires WES be ordered by or in consultation with a medical geneticist or maternal-fetal medicine specialist for prenatal WES. The record states a pre-test discussion occurred with a genetic specialist, meeting the 'in consultation with' requirement per policy.",Yes,"Policy lists 'multiple congenital anomalies (must affect different organ systems)' as an indication for prenatal WES. Patient has multiple structural (congenital) anomalies on fetal imaging, satisfying this medical indication.",No,Policy requires that chromosome microarray analysis (CMA) and/or karyotyping have been performed and were uninformative prior to prenatal WES. The patient information documents only Fragile X testing (nondiagnostic) and does not state CMA/karyotype were performed.,Yes,"Policy lists family history (other first- or second-degree family members with similar clinical features) as a relevant criterion. The patient has a maternal aunt with dysmorphic features, which is relevant per policy.",Not Specified,"The policy 'strongly recommends' genetic counseling prior to WES/WGS but does not state a mandatory counseling requirement for coverage; although the patient had pre-test discussion with a genetic specialist, the policy does not define a required counseling condition to adjudicate coverage.",81415,Policy's applicable codes list 81415 for exome sequence analysis (exome/proband); this best corresponds to the requested prenatal WES.,No,"Per the UnitedHealthcare policy, prenatal WES is medically necessary only when all listed criteria are met (including prior CMA and/or karyotype that were uninformative and appropriate fetal sample obtained). The record lacks documentation that CMA/karyotype were performed and uninformative and lacks documentation of the fetal sample source, so full policy criteria are not demonstrated; therefore coverage cannot be approved based on the provided information.",36940,2080,39020
Case5380,rag,all_correct,iter1,WGS,The patient information explicitly states whole genome sequencing (WGS) is requested.,Not Specified,"The UHC policy does not impose an absolute age cutoff for WGS; it lists phenotype-based age references (e.g., epileptic encephalopathy with onset before 3 years) but no strict age exclusion. The infant (8 weeks) does not conflict with those age references, but the policy’s criteria are phenotype-driven rather than strictly age-based.",Yes,"Policy requires WGS be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The case was referred by neurology (a neurologist), meeting the ordering-provider requirement per policy.",No,"UHC WGS coverage requires specific clinical indication(s): either epileptic encephalopathy with onset before age 3 or two or more listed features. The infant has seizure-like events/BRUE but no documented diagnosis of epileptic encephalopathy and lacks two or more of the listed features. Additionally, the policy requires that neither CMA nor WES have been performed (see Q4), which is not met.",No,"The policy for WGS states as a prerequisite that neither CMA nor WES have been performed. The patient has already had CMA (nondiagnostic), therefore the policy’s prior-test requirement for WGS is not satisfied.",No,"The policy lists family history/consanguinity as an eligibility feature (e.g., other first- or second-degree family members with similar clinical features or consanguinity). The provided family history (maternal short stature) does not constitute a family history of similar features to the infant’s seizure presentation nor consanguinity, so the family-history criterion relevant to eligibility is not met.",Not Specified,"The policy states genetic counseling is 'strongly recommended' prior to WES/WGS but does not make pre-test counseling an explicit coverage requirement. The family declined pre-test counseling, but that does not override policy coverage criteria which do not mandate counseling as a condition of coverage.",81425,"Policy Applicable Codes map whole genome sequence analysis to CPT code 81425 ('Genome (e.g., unexplained constitutional or heritable disorder or syndrome); sequence analysis'), which corresponds to WGS.",No,"Per the UHC WGS coverage criteria, WGS is allowed only when clinical criteria are met and 'neither CMA nor WES have been performed.' The patient had prior CMA (nondiagnostic) and does not meet the required specific clinical indication (no documented epileptic encephalopathy and not ≥2 listed features). Therefore the requested WGS does not meet policy coverage criteria.",36943,3459,40402
Case15570,rag,all_correct,iter1,BRCA1/2,The clinical note states the clinician requested BRCA1 and BRCA2 testing. Basis: patient information indicating BRCA1 and BRCA2 were ordered.,No,"Policy explicitly states genetic testing in minors for BRCA1/BRCA2 is considered investigational. The patient is 15 years old, so age-based eligibility is not met. Basis: 'Genetic testing in minors ... is considered investigational.'",No,Policy requires testing be performed in a setting with suitably trained providers who can give pre- and post-test counseling. The ordering clinician is a general pediatrician and there is no documentation of appropriate genetic counseling or that the provider meets the 'suitably trained' requirement. Basis: 'Genetic testing should be performed in a setting that has suitably trained health care providers ... who can give appropriate pre- and post-test counseling.',No,"Policy defines clinical indications (personal/family history of BRCA-related cancers or >5% prior probability). The patient has Hirschsprung disease, no personal cancer history, and no family history of cancer; thus does not meet any medical indication. Basis: policy criteria for unaffected individuals require specific family history or probability >5%.",Not Specified,"Policy 'strongly recommends' testing an affected family member first when possible, but does not state an absolute required prior test. The record lacks affected-family testing, but the policy frames this as recommendation rather than an explicit prerequisite. Basis: 'it is strongly recommended that an affected family member be tested first whenever possible.'",No,"Policy includes family history criteria for eligibility; the patient has no documented family history of cancer (mother has bipolar disorder only), so family history criteria are not met. Basis: policy requires close relatives with BRCA-related cancers for testing of unaffected individuals.",No,Policy requires testing be performed with appropriate pre-test genetic counseling by experienced providers. There is no documentation of pre-test genetic counseling for this patient. Basis: 'Genetic counseling ... experts recommend formal genetic counseling in most cases' and requirement for suitably trained providers.,Not Specified,The provided FEP policy document does not specify CPT/billing codes for BRCA1/BRCA2 testing. Basis: no CPT codes listed in the policy text supplied.,No,Per the policy the patient is a minor (testing in minors is considered investigational) and has no personal or family history meeting the policy's criteria; additionally required genetic counseling/setting is not documented. Therefore BRCA1/2 testing is not covered. Basis: 'Genetic testing in minors ... is considered investigational' and eligibility criteria for unaffected individuals require qualifying family history or >5% prior probability plus counseling requirements.,18943,2194,21137
Case5834,rag,all_correct,iter1,CMA,Patient information explicitly states the test being requested is chromosomal microarray (CMA); the policy is the BCBS_FEP CMA policy.,Not Specified,The policy's coverage statement refers to 'individuals' with developmental delay/intellectual disability and does not set an explicit age cutoff; therefore no specific age-based eligibility criteria are specified.,Not Specified,The policy does not define specific ordering-provider specialty or credential requirements for CMA (it discusses genetic counseling expertise but not ordering-provider restrictions).,Yes,The policy states CMA may be considered medically necessary as first-line testing for 'apparent nonsyndromic developmental delay/intellectual disability'; the patient has lifelong severe intellectual disability meeting this indication.,Not Specified,"The policy does not require completion of specific prior tests before CMA. Although guidelines referenced recommend fragile X testing as part of first-tier evaluation along with CMA, no explicit prerequisite tests are defined in the policy.",Not Specified,The policy's coverage criteria are based on the patient's developmental/intellectual disability or congenital anomalies and do not specify family history or consanguinity criteria relevant to CMA eligibility; the patient's maternal ovarian cancer history is not addressed by the policy for CMA.,Yes,"The policy recommends formal genetic counseling and states it should be performed by someone with genetic expertise; the patient had pre-test counseling with a genetic counselor and plans for post-test follow-up, meeting the counseling expectations described.",Not Specified,"The provided policy document does not list or map CPT codes to CMA testing, so no specific CPT code is specified in the policy text.",Yes,"Per the policy, CMA 'may be considered medically necessary as first-line testing' for apparent nonsyndromic intellectual disability; the patient meets that clinical indication, has had genetic counseling, and no disqualifying prior-test or age restrictions are specified—so CMA is covered under the policy.",15715,1704,17419
Case1501,rag,all_correct,iter1,WES,Patient record states Whole Exome Sequencing (WES) is being ordered.,Yes,"Policy age-related criteria include global developmental delay (onset <5 years) and intellectual disability diagnosed by 18. The patient is 2 years old with developmental concerns, meeting the age-related presentation described in the WES coverage rationale.",Yes,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the ordering provider is a developmental pediatrician.",Yes,"Policy medical necessity: WES is covered when clinical history strongly suggests a genetic cause and features such as multiple congenital anomalies and/or global developmental delay are present. The patient has multiple congenital anomalies and ongoing developmental concerns, and prior karyotype was nondiagnostic.",Not Specified,"Policy does not mandate prior specific tests (e.g., CMA) before postnatal WES; it only recommends targeted testing if a specific syndrome is suspected. The patient had a nondiagnostic karyotype, but no policy-required prior test is specified for this scenario.",No,"Policy lists family history of other first- or second-degree members with similar clinical features or consanguinity as relevant criteria. The patient’s noted family history (mother with Long QT) is not described as similar clinical features or consanguinity, so the family history does not meet the policy-specified family/consanguinity criterion.",Yes,"Policy states genetic counseling is strongly recommended prior to WES/WGS. The patient completed pre-test genetic counseling with plans for post-test follow-up, meeting the counseling recommendation in the policy.",81415,Policy lists CPT 81415 for exome (sequence analysis) for a proband; this corresponds to the WES requested.,Yes,"Under the policy WES is medically necessary when ordered by a developmental pediatrician and the individual has features such as multiple congenital anomalies and developmental delay. The 2-year-old patient has multiple congenital anomalies, developmental concerns, nondiagnostic prior karyotype, appropriate ordering provider, and completed pre-test counseling—meeting coverage criteria.",36937,2131,39068
Case10427,rag,all_correct,iter1,WGS,Patient clinical information explicitly states whole genome sequencing (WGS) is being requested.,Yes,"Policy includes age-related features (e.g., 'hypotonia or hypertonia in infancy') for WGS; the patient is an 8‑week‑old infant with hypotonia, which meets the age‑related criterion.",Yes,"Policy requires WGS to be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the test was ordered by/through a neurologist, meeting the requirement.",Yes,Policy requires clinical history suggesting a genetic cause plus qualifying features. The infant has significant hypotonia in infancy and a first‑degree relative (older sibling) with unexplained developmental regression — meeting ≥2 listed features and a clinical history suggestive of genetic etiology.,Yes,"Policy for WGS requires that neither CMA nor WES have been performed. Patient had nondiagnostic FISH but no CMA or WES, satisfying the prior‑test requirement.",Yes,"Policy lists 'other first‑ or second‑degree family member(s) with similar clinical features' as a qualifying feature. The patient has an older sibling with unexplained developmental regression, so relevant family history is present.",Not Specified,"Policy states genetic counseling is 'strongly recommended' prior to WES/WGS but does not make counseling a formal coverage requirement; patient did receive pre‑test counseling, but counseling is not specified as mandatory in the coverage criteria.",81425,"Policy applicable codes list 81425 for 'Genome (e.g., unexplained constitutional or heritable disorder or syndrome); sequence analysis,' which corresponds to WGS for the proband.",Yes,"Under the policy WGS is medically necessary when all criteria are met. The patient meets requirements: neurologist ordering, nonspecific presentation (hypotonia) with ≥2 qualifying features (hypotonia in infancy and affected sibling), neither CMA nor WES performed, and age appropriate — therefore WGS is covered per the policy.",36955,2439,39394
Case8485,rag,all_correct,iter1,WES,Patient clinical information explicitly states whole exome sequencing (WES) has been ordered.,Yes,"Policy requires member be <21 years of age for ES; patient is 8 years old, which meets the age criterion (policy: 'Member is <21 years of age').",Not Specified,The Cigna ES policy requires an appropriate genetic/family history evaluation and a clinical letter but does not specify a required ordering provider specialty/type; no explicit ordering-provider specialty requirement is stated.,No,"Policy requires specific clinical indications (e.g., global developmental delay onset <5, moderate/severe ID after formal assessment, multiple congenital anomalies, or other defined criteria). The patient has hypotonia and motor delay but does not meet any of the policy's explicit listed indications or documented formal assessments; thus the defined medical-necessity criteria are not met.",Not Specified,"Policy requires documentation of previous tests and that prior ES/WGS not have been performed; it does not universally require specific prior testing (e.g., CMA) for all presentations. The patient had Fragile X testing (nondiagnostic) and has no prior ES/WGS, but the policy does not define a specific mandatory prior-test set for this presentation.",Not Specified,"Patient has a sibling with autism (family history present), but the policy does not define family history/consanguinity as a standalone explicit eligibility criterion for ES in this context; family history is part of the required genetic/family history evaluation but no specific family-history threshold is specified.",Not Specified,"ACMG recommendations for pretest counseling by a medical geneticist/genetic counselor are cited in the policy, but the ES 'medically necessary' criteria do not explicitly mandate documented genetic counseling as a required element; the patient's lack of pretest counseling is noted but the policy does not state it as an absolute coverage requirement.",81415,Policy lists CPT 81415 as the appropriate code to bill for proband exome sequencing ('81415 should be billed for the proband').,No,"Coverage requires ALL policy criteria be met (including documented appropriate genetic/family history evaluation with clinical letter and meeting one of the specified clinical indications). The patient lacks documentation of the required clinical evaluation/letter, does not clearly meet the policy's specified clinical indication criteria, and pretest counseling was not performed; therefore ES does not meet the policy's medical necessity requirements.",10471,2581,13052
Case11795,rag,all_correct,iter1,WES,Patient information states chromosomal microarray was nondiagnostic and 'whole exome sequencing (WES) is being ordered.',Yes,"Policy addresses infants/children (BRUE defined for infants <1 year) and the patient is a three-week-old infant, so the patient's age falls within the age groups described in the policy (infant/child).",No,The policy requires documentation that the individual has been evaluated by a clinician with expertise in clinical genetics (policy statement #1). The patient record does not document an evaluation by a clinician with expertise in clinical genetics (only referral by a cardiologist and completion of pre-test counseling).,Yes,"The policy lists high-risk BRUE with significantly abnormal ECG (possible channelopathies/arrhythmias/cardiomyopathy) as a clinical feature suggesting genetic disease; the patient has a high-risk BRUE and markedly abnormal ECG, meeting the medical indication criteria.",Yes,"Policy indicates WES is appropriate when a genetic etiology is considered despite previous genetic testing (e.g., chromosomal microarray). The patient had a CMA that was nondiagnostic, meeting the prior testing expectation.",Yes,"Policy cites family history of developmental delay and BRUE in a sibling as relevant; patient has a sibling with moderate–severe intellectual disability, which is a listed relevant family history.",Yes,"Policy requires genetic counseling and evaluation by genetics; patient information states pre-test genetic counseling was completed with plans for post-test follow-up, satisfying the counseling requirement portion.",Not Specified,The provided policy document does not specify particular CPT codes for WES; no CPT-to-service mapping is present in the policy text.,No,"Although the patient meets clinical indications (high-risk BRUE, markedly abnormal ECG) and prior CMA was nondiagnostic and counseling completed, the policy requires documentation of evaluation by a clinician with expertise in clinical genetics as an ALL required criterion for standard WES. That documentation is not present in the patient information, so coverage criteria are not fully met.",14874,2372,17246
Case2007,rag,all_correct,iter1,BRCA1/2,Clinical information states the patient was referred for BRCA1 and BRCA2 testing; policy addresses BRCA1/BRCA2 germline testing.,Yes,"Policy lists 'personal history of breast cancer diagnosed at age ≤45 years' as a medical-necessity criterion; the patient is 18, which meets this age-based criterion.",Not Specified,The policy requires testing be performed in a setting with suitably trained providers and genetic counseling but does not specify required ordering provider specialty or limit ordering to particular provider types.,Yes,Policy states BRCA1/2 testing is medically necessary for individuals with a personal history of breast cancer diagnosed ≤45 years; the patient (age 18) has breast cancer and therefore meets a defined clinical indication.,Not Specified,The policy does not require prior specific genetic tests before BRCA1/2 testing for an affected individual meeting clinical criteria; the documented prior CMA (nondiagnostic) is not a required prior test per policy.,Yes,"Policy includes having a close blood relative with breast cancer diagnosed ≤50 years as relevant; the patient’s mother had breast cancer at age ≤50, which is a relevant family-history criterion.",Yes,"Policy requires appropriate pre- and post-test genetic counseling by experienced providers; the patient completed pre-test counseling and will return for post-test counseling, meeting the counseling requirement in the policy.",Not Specified,"The provided policy document does not list or map CPT codes to BRCA1/BRCA2 testing, so a specific CPT code is not specified in the policy text.",Yes,"Under the policy, BRCA1/2 testing is medically necessary for individuals with a personal history of breast cancer diagnosed ≤45 years; the patient is 18 with breast cancer and completed pre-test counseling, so testing is covered.",18944,1951,20895
Case7297,rag,all_correct,iter1,WES,Patient record explicitly states whole exome sequencing (WES) is being pursued to identify an underlying genetic etiology.,Not Specified,"Policy criteria for WES list clinical features (e.g., multiple congenital anomalies) but do not impose an age cutoff for WES in this indication; no age-based exclusion/requirement is specified for this scenario.",Not Answerable,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the patient information does not state which provider actually placed the WES order.",Yes,Policy lists 'multiple congenital anomalies (must affect different organ systems)' as an explicit criterion for WES and the 3‑year‑old has multiple congenital anomalies affecting different organ systems.,Not Specified,"The policy does not mandate specific prior tests for postnatal WES in cases of multiple congenital anomalies; although the patient had a nondiagnostic karyotype, the policy does not require CMA/karyotype prior to postnatal WES in this indication.",No,"Policy family history criteria refer to first/second‑degree relatives with similar clinical features or consanguinity; the only family history noted is a maternal aunt with ovarian cancer, which does not meet the policy's specified family/consanguinity criteria.",Yes,"Policy states genetic counseling is strongly recommended prior to WES and the patient had pre‑test counseling with a genetic specialist and planned post‑test follow‑up, meeting the counseling recommendation.",81415,Policy's applicable CPT codes list 81415 for exome (sequence analysis) consistent with WES.,No,"Medically necessary criteria are met (multiple congenital anomalies, counseling performed), but the policy explicitly requires WES be ordered by certain specialists and the record does not document that the ordering provider meets those specialty requirements; coverage cannot be confirmed under the policy.",36959,2603,39562
Case2666,rag,all_correct,iter1,BRCA1/2,Patient explicitly is 'undergoing BRCA1/2 testing' per the clinical information; policy addresses BRCA1 and BRCA2 germline testing.,Yes,Policy specifies testing in minors is investigational; the patient is 21 (an adult). Therefore she meets age-related eligibility per policy (minors excluded).,Yes,"Policy requires testing be performed in a setting with suitably trained providers and that genetic counseling be provided. The patient had pre-test counseling with a genetic specialist and plans for post-test follow-up, meeting the provider/counseling setting requirement.",Yes,"Policy allows testing for an unaffected individual who has a 1st-degree relative meeting any criterion listed for Patients With Cancer. The patient's father (a 1st-degree relative) has metastatic prostate cancer, which is a listed criterion for affected individuals.",Not Specified,"Policy 'strongly recommends' testing an affected family member first when possible, but does not make prior testing of an affected relative an absolute coverage prerequisite for an unaffected 1st-degree relative whose relative meets policy cancer criteria. The policy does not specify a mandatory prior-test requirement for this scenario.",Yes,"Family history criteria are specified in the policy; the patient has a relevant family history (father with metastatic prostate cancer), which is a qualifying first-degree relative per policy.",Yes,"Policy specifies genetic counseling by experienced providers is required/expected. The patient completed pre-test counseling with a genetic specialist and has plans for post-test follow-up, satisfying counseling requirements.",81162,"Among provided CPT options, 81415 and 81425 correspond to exome/genome sequencing (WES/WGS). The requested test is BRCA1/2 single-gene germline testing; 81162 is the CPT option listed that best corresponds to BRCA1/2 testing in this selection set.",Yes,"Per policy, germline BRCA1/2 testing is medically necessary for an unaffected individual with a 1st-degree relative meeting cancer-affected criteria; the patient's father has metastatic prostate cancer. Counseling and testing setting requirements are met, so testing is covered.",18944,2205,21149
Case13983,rag,all_correct,iter1,WGS,Patient information explicitly states whole genome sequencing (WGS) is being pursued.,Yes,"Policy includes infants/children (neonatal/pediatric) among populations for WES/WGS; the patient is a 7-week-old infant, which meets the policy's age context for pediatric/infant testing.",Not Specified,"The policy text specifies an evaluation by a clinician with expertise in clinical genetics for standard WES but does not define explicit ordering-provider specialty requirements for WGS/rapid WGS; the ordering provider here (gynecologist) is not documented as a genetics clinician, but the policy does not explicitly prohibit that.",Yes,"Policy examples of clinical features suggesting a genetic disease explicitly list a high-risk BRUE with a significantly abnormal ECG (possible channelopathies/arrhythmias), which matches the patient's presentation.",Not Specified,"The policy specifies prior testing requirements (eg, CMA or targeted single-gene testing) for standard WES but does not define explicit prior-test requirements for WGS/rapid WGS in the policy text provided; the patient had nondiagnostic FISH but no CMA documented.",Yes,"The policy lists family history items (eg, developmental delay, arrhythmia) as relevant; the patient has a maternal uncle with unexplained developmental regression, satisfying a listed family-history criterion.",Yes,"Policy requires or recommends genetic counseling (standard WES criterion 1 and the Genetic Counseling section); the patient had pre-test counseling with a genetic counselor and post-test follow-up is planned, meeting counseling expectations.",Not Specified,"The provided policy document does not list or map CPT codes to WES or WGS, so no specific CPT code is specified in the policy text.",No,"Although the patient's clinical features (high-risk BRUE with significantly abnormal ECG and positive family history) meet medical-indication examples in the policy, medically necessary coverage for WGS in the policy is limited: rapid WGS is authorized for critically ill infants in the NICU/PICU when ordered, and standard WGS is considered investigational in other situations. The record does not document that the infant is critically ill and in an intensive care unit at the time of ordering (required for rapid WGS), and standard (non-rapid) WGS is investigational per the policy; therefore WGS is not covered per the policy.",14898,3658,18556
Case15458,rag,all_correct,iter1,BRCA1/2,Patient is being evaluated specifically for BRCA1 and BRCA2 testing per the clinical information; policy FEP 2.04.02 addresses BRCA1 and BRCA2 testing.,Yes,"Policy lists age-based indications for BRCA testing in individuals with personal history of breast cancer (e.g., diagnosed ≤45 years). The patient is 19 with breast cancer, meeting the ≤45-year criterion (Policy: ""Personal history of breast cancer and 1 or more of the following: Diagnosed at age ≤45 years"").",Yes,"Policy requires testing be performed in a setting with ""suitably trained health care providers who can give appropriate pre- and post-test counseling."" The ordering provider is a nurse practitioner and the patient completed pre-test genetic counseling, satisfying the policy's requirement for a suitably trained provider and counseling setting.",Yes,"Policy defines medical indications for BRCA testing in cancer-affected individuals including (a) personal history of breast cancer diagnosed ≤45 years and (b) diagnosed at any age with ≥1 close blood relative with ovarian carcinoma or metastatic/intraductal/cribriform prostate cancer. The patient is 19 with breast cancer and has a maternal aunt with ovarian cancer and a close relative with metastatic/intraductal prostate cancer, meeting these criteria.",Not Specified,The policy does not mandate completion of any specific prior test before BRCA1/2 germline testing; prior limited testing is discussed but no required antecedent test is specified. The prior nondiagnostic FISH is not specified as a required prior test in the policy.,Yes,"Policy explicitly uses family history criteria (close relatives with ovarian cancer or metastatic/intraductal prostate cancer) as indications for testing. The patient has a maternal aunt with ovarian cancer and a close relative with metastatic/intraductal prostate cancer, meeting the family-history criteria.",Yes,"Policy requires testing be performed with appropriate pre- and post-test genetic counseling by experienced providers. The patient completed pre-test genetic counseling and plans post-test follow-up, satisfying the counseling requirement in the policy.",Not Specified,The provided FEP policy document does not list or map specific CPT codes to BRCA1/2 testing; therefore a CPT code cannot be determined from the policy text alone.,Yes,"Per FEP policy, BRCA1/2 testing is medically necessary for cancer-affected individuals who meet listed criteria. The patient (19-year-old with breast cancer) meets age-based and family-history criteria (breast cancer diagnosed ≤45; close relatives with ovarian and metastatic/intraductal prostate cancer), testing is ordered in a counseling setting, and pre-test counseling was completed—thus the policy supports coverage.",18955,1876,20831
Case18868,rag,all_correct,iter1,WGS,Patient information explicitly states whole genome sequencing (WGS) has been ordered to assess for hereditary cancer predisposition.,No,"The policy's GS coverage criteria explicitly require the member to be <21 years of age. The patient is 41 years old, so she does not meet the age-based eligibility criterion.",No,"The policy requires an appropriate genetic and family history evaluation with a clinical letter detailing specific items (differential diagnoses, testing algorithm, previous tests/results, recommendation that GS is most appropriate, predicted impact on care). Although the patient was evaluated by a medical geneticist, there is no documentation provided of the required clinical letter or pre-test counseling, so ordering/provider requirements are not satisfied per the policy.",No,The policy defines specific medical indications (largely pediatric/neurodevelopmental/congenital anomaly presentations) for GS; adult hereditary cancer predisposition is not listed as an accepted indication. The patient's diagnosis (primary peritoneal carcinoma) does not meet the enumerated clinical indications.,No,"The policy requires that the member not have prior exome/genome sequencing and requires documentation of prior tests and results in the clinical letter. While no prior exome/genome is reported (which would satisfy the 'not had previous ES/GS' requirement), the required clinical documentation and pre-test counseling were not provided, so prior test/documentation requirements are not complete per the policy.",Not Specified,"The policy requires an evaluation of genetic and family history to be documented, but it does not define family history or consanguinity as a standalone eligibility criterion for adult GS in this context. The patient does have a family history concern (mother with hematologic disorder), but the policy does not specify that this family history alone makes the patient eligible.",No,"The policy (and cited ACMG guidance within it) requires pre-test genetic counseling by a medical geneticist or affiliated genetic counselor with written documentation. The supplied patient materials state there was no documented pre-test genetic counseling, so counseling requirements are not met.",81425,Policy procedure coding lists 81425 as the appropriate CPT code for genome sequencing (proband) when analyzing the entire genome; WGS should be billed with 81425 per the guideline.,No,"Per the policy, all GS criteria must be met, including age <21 and required documentation/counseling. The patient is 41 and lacks documented required clinical documentation/pre-test counseling; therefore GS (WGS) is not covered under the provided criteria.",9161,2278,11439
Case10917,rag,all_correct,iter1,WES,Patient information explicitly states whole exome sequencing (WES) has been ordered.,Not Specified,The UHC WES policy does not impose a specific minimum or maximum age restriction for outpatient WES; pediatric/infant use is discussed but no explicit age-based eligibility cutoff is stated in the coverage criteria.,Yes,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the patient was evaluated and WES ordered by a medical geneticist, meeting the provider requirement.",No,"Policy coverage requires the clinical presentation plus defined features (e.g., multiple congenital anomalies or two-or-more listed features such as IEM‑suggestive labs plus another feature). The infant has a laboratory abnormality (conjugated hyperbilirubinemia) but lacks documentation of a second listed feature (or clearly ‘similar’ affected family members), so the specific WES medical-indication criteria are not met per the policy.",Not Specified,"The policy does not mandate prior testing (e.g., CMA) before outpatient/post‑discharge WES in the general non‑prenatal scenario; it only specifies prior testing requirements for certain prenatal contexts or when a specific syndrome is suspected (targeted testing). No universal prior-test requirement is specified for this case.",Yes,"The policy lists ‘other first‑ or second‑degree family member(s) with similar clinical features’ and consanguinity as relevant criteria. The patient has a family history (older sibling with multiple congenital anomalies), which constitutes relevant family history per the policy.",Yes,"Policy states genetic counseling is strongly recommended prior to WES/WGS. The patient had pre‑test counseling with a genetic specialist, which meets the policy's counseling recommendation.",81415,Policy applicable codes list 81415 for exome (sequence analysis) which corresponds to WES ordered for the proband.,No,"Applying the UHC WES coverage rationale: WES is medically necessary only when the clinical history plus required qualifying features are met. Although the infant has an abnormal laboratory finding suggestive of possible IEM and a sibling with congenital anomalies, the documentation does not demonstrate the specific combination of features required by the policy (e.g., multiple congenital anomalies or two or more listed features or clearly similar affected family members). Therefore, under the policy criteria the test is not supported as covered.",36946,3409,40355
Case12792,rag,all_correct,iter1,BRCA1/2,"Patient was referred specifically for ""BRCA1/2 testing"" per the provided clinical information; policy pertains to BRCA1, BRCA2, PALB2 testing.",No,"Policy explicitly states: ""Genetic testing in minors for BRCA1, BRCA2, and PALB2 variants... is considered investigational."" The patient is 12 years old, a minor, and therefore does not meet the policy's age-related eligibility.",Yes,"Policy requires testing to be performed in a setting with ""suitably trained health care providers"" who can give pre- and post-test counseling. The clinical information states pre-test genetic counseling has been completed and post-test follow-up is planned, satisfying the policy's provider/counseling setting requirement.",No,"Policy defines specific medical indications (personal or family cancer history or >5% prior-probability, etc.). The patient has congenital choanal atresia and a maternal growth abnormality but no documented personal or family history of cancers meeting the policy criteria; thus the patient does not meet a defined medical indication.",Not Specified,"The policy describes some situations where prior limited testing or affected-relative testing strategy is relevant, but it does not specify a required prior test for this clinical scenario; the provided patient information (nondiagnostic FISH) is not identified in the policy as a required prior test for BRCA1/2 testing.",No,"Policy includes family-history-based eligibility criteria for BRCA1/2 testing. The patient record contains no report of a family history of breast, ovarian, pancreatic, or prostate cancer; only a maternal growth abnormality is reported, which does not meet the policy's family-history criteria.",Yes,"Policy states genetic counseling should be performed and is recommended. The clinical information documents that pre-test genetic counseling has been completed and post-test follow-up is planned, meeting the policy's genetic counseling requirement.",Not Specified,The provided policy document does not list or map CPT codes to BRCA1/2 testing; no CPT code selection can be made solely from the policy text and patient information.,No,"Per the policy: ""Genetic testing in minors for BRCA1, BRCA2, and PALB2 variants for hereditary breast and ovarian cancer syndrome is considered investigational."" The patient is a 12-year-old minor; despite counseling being completed, the policy deems such testing investigational in minors and therefore not covered.",18927,1823,20750
Case8710,rag,all_correct,iter1,WES,Patient clinical information explicitly states whole exome sequencing (WES) has been requested.,Yes,Policy age-related items reference criteria diagnosed by age 18; patient is 12 and thus within the age limits referenced for pediatric indications (policy requires features diagnosed by 18 years where applicable).,Yes,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the ordering provider is a developmental pediatrician (meets requirement).",Yes,"Policy coverage requires clinical presentation nonspecific and appropriate features. Patient has autism spectrum disorder plus at least one additional abnormality affecting another organ system (meets the policy's multi-feature neurodevelopmental criteria) and a family history of neurologic disease (second-degree relative), satisfying the clinical indications in the WES coverage rationale.",Not Specified,"The policy does not require prior CMA or other specific prior testing for postnatal WES (prenatal WES requires prior CMA/karyotype), and no mandatory prior-test sequence is specified for this outpatient pediatric scenario; prior karyotype was nondiagnostic but policy does not mandate additional prior testing in this context.",Yes,"Policy lists 'other first- or second-degree family member(s) with similar clinical features' and consanguinity as relevant features; patient has a paternal uncle (a second-degree relative) with neurologic disease (dystonia and ataxia), which is a relevant family history per the policy.",Not Specified,"Policy states genetic counseling is 'strongly recommended' prior to WES but does not make pre-test counseling an explicit coverage requirement; no pre-test counseling was documented for this case, but counseling is not mandated by the policy as a condition of coverage.",81415,"Policy's applicable CPT codes list 81415 for 'Exome (e.g., unexplained constitutional or heritable disorder or syndrome); sequence analysis', which corresponds to clinical WES requested.",Yes,"Under the UnitedHealthcare WES coverage rationale, WES is medically necessary when ordered by an approved provider and the clinical presentation suggests a genetic cause with appropriate features. Patient is 12, referred by a developmental pediatrician, has ASD plus at least one additional organ-system abnormality and relevant family history, meeting the policy's clinical criteria for WES; therefore coverage is supported.",36953,2951,39904
Case16246,rag,all_correct,iter1,BRCA1/2,Patient is being referred specifically for BRCA1 and BRCA2 testing per the clinical information; policy includes BRCA1/2 gene testing as a discrete test.,Yes,"Policy: ""BRCA1/2 gene testing is proven and medically necessary for individuals with a personal history of Breast Cancer diagnosed at age 65 or younger."" Patient is 35, which meets the ≤65 age criterion.",Not Specified,The policy strongly recommends pre-test genetic counseling and genetic expertise for interpretation but does not mandate a specific ordering provider specialty or require the order to come from a genetics specialist for BRCA1/2 testing.,Yes,Policy medical indication: individuals with a personal history of breast cancer diagnosed at age 65 or younger qualify for BRCA1/2 testing; patient has personal history of breast cancer diagnosed before age 50 (age 35).,Not Specified,Policy does not list required prior diagnostic tests that must be completed before BRCA1/2 germline testing; it recommends pre-test counseling but does not require prior tests.,Yes,"Policy defines BRCA-related cancers to include pancreatic cancer and recognizes first- and second-degree relatives in family-history criteria; patient's uncle (a second-degree relative) had pancreatic cancer, which is relevant per policy.",Not Specified,"Policy states ""Pre-test genetic counseling is strongly recommended"" but does not make counseling a formal coverage requirement; patient has not had pre-test counseling, and the policy does not require it as a condition of coverage.",81162,"CPT mapping in the policy: 81162 = BRCA1/BRCA2 gene analysis; full sequence analysis and full duplication/deletion analysis, which corresponds to standard BRCA1/2 testing requested.",Yes,"Per policy coverage rationale: ""BRCA1/2 gene testing is proven and medically necessary for individuals with a personal history of Breast Cancer diagnosed at age 65 or younger."" Patient is a 35-year-old woman with breast cancer, meeting policy criteria for coverage.",38615,1801,40416
Case14017,rag,all_correct,iter1,WES,Patient information explicitly states whole exome sequencing (WES) has been ordered to evaluate a possible genetic etiology.,Yes,"Policy applies to children and BRUE is defined for infants <1 year; the patient is 7 weeks old (<1 year), satisfying age-related applicability in the policy (infant BRUE example).",No,"Policy requires documentation that the individual has been evaluated by a clinician with expertise in clinical genetics; the record states evaluation by a general pediatrician (no documentation of evaluation by a clinician with genetics expertise), so ordering/provider requirement is not met.",No,"Policy limits WES as medically necessary to (a) unexplained congenital or neurodevelopmental disorders in children when ALL criteria met or (b) rapid WES for critically ill NICU/PICU infants meeting specific criteria. Although BRUE with recurrent witnessed seizure-like events is listed as a clinical feature suggesting genetic disease, the infant is not documented as critically ill/in intensive care nor as having an unexplained congenital or neurodevelopmental disorder; therefore the specific medical-indication criteria in the policy are not met.",No,"Policy expects prior genetic testing such as chromosomal microarray analysis (CMA) and/or targeted single-gene testing before standard WES; the patient had only a nondiagnostic karyotype (no CMA or targeted testing documented), so required prior testing was not completed.",Yes,"The policy specifies family history criteria as relevant (eg, family history of genetic disease/neurologic conditions); the patient has a maternal uncle with a movement disorder (dystonia/ataxia), which meets the policy's family-history relevance.",Yes,"Policy requires genetic counseling prior to testing; patient information documents that pre-test genetic counseling was completed with plans for post-test follow-up, satisfying the counseling requirement.",81415,"The requested test is whole exome sequencing (WES); among the provided CPT options, 81415 corresponds to clinical exome sequencing and best matches the ordered WES.",No,"Under the FEP policy WES is covered only when all criteria are met (evaluation by genetics expert, appropriate prior testing, and appropriate medical indication or critical illness criteria). Although age, family history, and counseling are favorable, required prior testing (eg, CMA) and documented evaluation by a clinician with genetics expertise and the policy-defined medical-indication (or critical-illness/ICU status for rapid WES) are not met; therefore the test is not covered per the policy.",14857,3303,18160
Case5674,rag,all_correct,iter1,WES,Patient information states the team plans whole exome sequencing (WES) to investigate a possible genetic epilepsy syndrome.,Yes,"Policy applies to 'children' for standard WES; the patient is a 9-year-old child, meeting the pediatric (child) age applicability in the policy.",Yes,"Policy requires the individual be evaluated by a clinician with expertise in clinical genetics and counseled about testing risks. The record documents multiple visits with a genetic counselor and arrangements for genetics follow-up, satisfying the policy's provider/counseling requirement despite the ordering clinician being a general practitioner.",Yes,"Policy lists 'persistent seizures' as an example clinical feature suggesting a genetic disease; the patient has persistent seizures and prior nondiagnostic CMA, consistent with the policy's medical indication for WES.",Yes,"Policy requires prior genetic testing (eg, CMA and/or targeted testing) to have been performed and nondiagnostic before WES; the patient had a nondiagnostic chromosomal microarray (CMA), meeting this prior-test requirement.",Yes,"Policy cites family history such as sudden unexplained death in first- or second-degree relatives before age 35 as relevant. The patient has an uncle with sudden unexplained death before age 35, which is a specified relevant family history.",Yes,"Policy requires genetic counseling by an experienced individual; the patient had multiple visits with a genetic counselor and documented counseling, meeting the policy's counseling requirement.",81415,The requested test is whole exome sequencing (WES); CPT 81415 corresponds to clinical exome sequencing and best matches the requested WES.,Yes,"All mandatory policy criteria for medically necessary standard WES are met per FEP 2.04.102: pediatric patient evaluated/counseled by genetics expertise, prior CMA nondiagnostic, clinical phenotype (persistent seizures) consistent with a suspected genetic etiology, and potential to change management; therefore WES may be considered medically necessary under the policy.",14831,2234,17065
Case9773,rag,all_correct,iter1,CMA,Patient information explicitly states 'chromosomal microarray (CMA) ordered to assess for genomic copy number changes.' Basis: patient clinical information.,Yes,"Policy addresses CMA for 'infants or children' and as first-line testing for developmental delay/intellectual disability; the patient is a 2-year-old child, which meets the age scope described. Basis: FEP policy language that CMA is for infants/children and first-line in evaluation of developmental delay/ID.",Not Specified,The policy discusses genetic counseling and follow-up but does not specify required ordering provider specialty or type for CMA. Basis: no ordering-provider requirements listed in the policy.,Yes,Policy states CMA 'may be considered medically necessary as first-line testing' for individuals with apparent nonsyndromic developmental delay/intellectual disability; the patient has severe intellectual disability. Basis: FEP policy statement listing developmental delay/ID as covered indication.,Not Specified,The policy does not mandate completion of specific prior tests before CMA (it references guideline recommendations such as fragile X testing as part of first-tier evaluation but does not require prior testing as a coverage precondition). Basis: Policy guidelines discuss stepwise approaches but no explicit prior-test requirement for CMA coverage.,Not Specified,The policy does not set family history or consanguinity prerequisites for CMA coverage. The patient's note of a maternal aunt with an immunologic disorder is not addressed as a coverage criterion. Basis: no family-history eligibility criteria in the policy.,Not Specified,"Policy recommends formal genetic counseling and states it should be performed by experienced individuals, but it does not frame counseling as an explicit coverage requirement; patient completed pre-test counseling. Basis: policy text on genetic counseling is recommendation-focused, not a stated coverage prerequisite.",Not Specified,The policy document does not list or map CPT codes to CMA; no CPT code is specified in the provided policy text. Basis: absence of CPT code information in FEP policy.,Yes,"Under the policy, CMA 'may be considered medically necessary as first-line testing' for individuals with developmental delay/intellectual disability; the patient is a 2-year-old with severe intellectual disability and CMA was ordered. No policy exclusions or unmet coverage requirements were identified. Basis: FEP 2.04.59 policy statement that CMA is medically necessary for apparent nonsyndromic developmental delay/ID.",15707,1932,17639
Case18257,rag,all_correct,iter1,BRCA1/2,Patient is being evaluated for BRCA1/2 testing to assess hereditary breast and ovarian cancer risk; policy is the Cigna BRCA Analysis guideline.,Yes,"Policy age requirement for BRCA testing is ≥18 years for relevant analyses; the patient is 64, satisfying the age criterion.",Not Specified,"The policy specifies requirements for genetic counseling and that the rendering laboratory be qualified, but it does not specify or restrict the ordering provider specialty/type; therefore ordering provider requirements are not specified.",Yes,"Policy Full Sequence Analysis lists 'female with breast cancer diagnosis 50 years of age or younger' as an indication; the patient had breast cancer diagnosed at age ≤50, meeting a defined clinical criterion.",Yes,"Policy requires no previous BRCA full sequencing or deletion/duplication analysis prior to new BRCA testing; the patient has prior nondiagnostic CMA but no prior BRCA testing, satisfying the 'no previous BRCA testing' requirement.",No,Policy includes family-history-based criteria for BRCA testing; the patient's family history (a sibling with short stature) does not meet the policy's specified cancer family-history criteria.,No,The policy requires pre- and post-test genetic counseling by an appropriate provider for BRCA analyses; there is no documentation of prior genetic counseling for this patient.,81162,"Policy notes that when BRCA1/2 sequencing and deletion/duplication analysis are performed concurrently, CPT code 81162 (combined sequencing + del/dup) is likely most appropriate.",No,"Although the patient meets age and diagnostic criteria (breast cancer ≤50) and has no prior BRCA testing, the policy requires documented pre- and post-test genetic counseling which is not present; lacking this required counseling results in noncoverage per the policy criteria.",10263,2265,12528
Case10075,rag,all_correct,iter1,CMA,Patient clinical notes state consideration of chromosomal microarray (CMA) testing to evaluate for an underlying chromosomal/genetic etiology; prior CMA was nondiagnostic. Policy under review is specific to CMA.,Not Specified,The policy discusses postnatal use of CMA in infants/children but does not define explicit age cutoffs; the patient is a 4‑week‑old infant and no age-based exclusion or explicit age eligibility criteria are specified in the policy.,Not Specified,The policy does not state specific ordering provider/specialty requirements for CMA (it recommends genetic counseling by experienced individuals but does not restrict who may order the test).,No,"Policy states CMA is medically necessary as first-line for (1) apparent nonsyndromic developmental delay/ID, (2) ASD, or (3) multiple congenital anomalies not specific to a well‑delineated syndrome. The infant has meconium ileus (a single neonatal/intestinal issue) and no documented developmental delay, ASD, or multiple congenital anomalies; therefore the patient does not meet the policy's listed medical indications.",Not Specified,The policy does not mandate completion of any specific prior diagnostic tests before performing CMA in the covered indications; it does not provide required prior‑test steps for this clinical situation.,Not Specified,"Although the patient has a sibling with an inborn error of metabolism, the policy does not specify family history or consanguinity criteria as qualifying indications for CMA in this context.",Yes,"The policy states formal genetic counseling is recommended and should be performed by an individual with genetics expertise. The patient had pre‑test counseling with a genetic specialist and arrangements for post‑test follow‑up, which meets the policy's counseling expectation.",Not Specified,The policy document does not list or map CPT codes to chromosomal microarray testing; no CPT code is specified in the provided policy text.,No,"Based on the policy's coverage criteria, CMA is covered only for individuals with developmental delay/ID, ASD, or multiple congenital anomalies. The 4‑week‑old infant's presentation (meconium ileus, prior nondiagnostic CMA, family history of metabolic disease) does not meet the policy's specified medical indications for CMA, so the test is not covered under this policy.",15704,1858,17562
